<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN" "http://jats.nlm.nih.gov/publishing/1.1d3/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS Comput Biol</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">ploscomp</journal-id>
<journal-title-group>
<journal-title>PLOS Computational Biology</journal-title>
</journal-title-group>
<issn pub-type="ppub">1553-734X</issn>
<issn pub-type="epub">1553-7358</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.pcbi.1006228</article-id>
<article-id pub-id-type="publisher-id">PCOMPBIOL-D-18-00036</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3"><subject>Physical sciences</subject><subj-group><subject>Physics</subject><subj-group><subject>Thermodynamics</subject><subj-group><subject>Free energy</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Enzymology</subject><subj-group><subject>Enzyme chemistry</subject><subj-group><subject>Enzyme regulation</subject><subj-group><subject>Allosteric regulation</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Proteins</subject><subj-group><subject>Allosteric regulation</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical sciences</subject><subj-group><subject>Physics</subject><subj-group><subject>Condensed matter physics</subject><subj-group><subject>Solid state physics</subject><subj-group><subject>Crystallography</subject><subj-group><subject>Crystal structure</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Molecular biology</subject><subj-group><subject>Macromolecular structure analysis</subject><subj-group><subject>Protein structure</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Proteins</subject><subj-group><subject>Protein structure</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Enzymology</subject><subj-group><subject>Enzyme chemistry</subject><subj-group><subject>Enzyme regulation</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Engineering and technology</subject><subj-group><subject>Equipment</subject><subj-group><subject>Communication equipment</subject><subj-group><subject>Antennas</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pharmacology</subject><subj-group><subject>Drug research and development</subject><subj-group><subject>Drug discovery</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Cell biology</subject><subj-group><subject>Cell physiology</subject><subj-group><subject>Cell communication</subject></subj-group></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Reversing allosteric communication: From detecting allosteric sites to inducing and tuning targeted allosteric response</article-title>
<alt-title alt-title-type="running-head">Towards inducing and tuning targeted allosteric response</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
<name name-style="western">
<surname>Tee</surname>
<given-names>Wei-Ven</given-names>
</name>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Software</role>
<role content-type="http://credit.casrai.org/">Validation</role>
<role content-type="http://credit.casrai.org/">Visualization</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-6780-3313</contrib-id>
<name name-style="western">
<surname>Guarnera</surname>
<given-names>Enrico</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Software</role>
<role content-type="http://credit.casrai.org/">Supervision</role>
<role content-type="http://credit.casrai.org/">Validation</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-3315-8483</contrib-id>
<name name-style="western">
<surname>Berezovsky</surname>
<given-names>Igor N.</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Funding acquisition</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Project administration</role>
<role content-type="http://credit.casrai.org/">Resources</role>
<role content-type="http://credit.casrai.org/">Supervision</role>
<role content-type="http://credit.casrai.org/">Validation</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label> <addr-line>Bioinformatics Institute (BII), Agency for Science, Technology and Research (A*STAR), Matrix, Singapore</addr-line></aff>
<aff id="aff002"><label>2</label> <addr-line>Department of Biological Sciences (DBS), National University of Singapore (NUS), Singapore</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Papaleo</surname>
<given-names>Elena</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>Danish Cancer Society Research Center, DENMARK</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">igorb@bii.a-star.edu.sg</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>18</day>
<month>6</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<month>6</month>
<year>2018</year>
</pub-date>
<volume>14</volume>
<issue>6</issue>
<elocation-id>e1006228</elocation-id>
<history>
<date date-type="received">
<day>9</day>
<month>1</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>23</day>
<month>5</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-year>2018</copyright-year>
<copyright-holder>Tee et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.pcbi.1006228"/>
<abstract>
<p>The omnipresence of allosteric regulation together with the fundamental role of structural dynamics in this phenomenon have initiated a great interest to the detection of regulatory exosites and design of corresponding effectors. However, despite a general consensus on the key role of dynamics most of the earlier efforts on the prediction of allosteric sites are heavily crippled by the static nature of the underlying methods, which are either structure-based approaches seeking for deep surface pockets typical for “traditional” orthosteric drugs or sequence-based techniques exploiting the conservation of protein sequences. Because of the critical role of global protein dynamics in allosteric signaling, we investigate the hypothesis of reversibility in allosteric communication, according to which allosteric sites can be detected via the perturbation of the functional sites. The reversibility is tested here using our structure-based perturbation model of allostery, which allows one to analyze the causality and energetics of allosteric communication. We validate the “reverse perturbation” hypothesis and its predictive power on a set of classical allosteric proteins, then, on the independent extended benchmark set. We also show that, in addition to known allosteric sites, the perturbation of the functional sites unravels rather extended protein regions, which can host latent regulatory exosites. These protein parts that are dynamically coupled with functional sites can also be used for inducing and tuning allosteric communication, and an exhaustive exploration of the per-residue contributions to allosteric effects can eventually lead to the optimal modulation of protein activity. The site-effector interactions necessary for a specific mode and level of allosteric communication can be fine-tuned by adjusting the site’s structure to an available effector molecule and by the design or selection of an appropriate ligand.</p>
</abstract>
<abstract abstract-type="summary">
<title>Author summary</title>
<p>Recent advances in the development of allosteric drugs allow one to fully appreciate the sheer power of allosteric effectors in the avoiding toxicity, receptor desensitization and modulatory rather than on/off mode of action, compared to the traditional orthosteric compounds. The detection of allosteric sites is one of the major challenges in the quest for allosteric drugs. This work proposes a “reverse perturbation” approach for identifying allosteric sites as a result of a perturbation applied to the functional ones. We show that according to the traditional Monod-Changeux-Jacob’s definition of allostery, considering non-overlapping regulatory and functional sites is a critical prerequisite for the successful detection of allosteric sites. Using the reverse perturbation method, it is possible to determine wide protein regions with a potential to induce an allosteric response and to adjust its strength. Further studies on inducing and fine-tuning of allosteric signalling seem to be of a great importance for efficient design of non-orthosteric ligands in the development of novel drugs.</p>
</abstract>
<funding-group>
<funding-statement>Funding is provided by the Biomedical Research Council, Agency for Science, Technology, and Research (A*STAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
</funding-group>
<counts>
<fig-count count="10"/>
<table-count count="1"/>
<page-count count="26"/>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>PLOS Publication Stage</meta-name>
<meta-value>vor-update-to-uncorrected-proof</meta-value>
</custom-meta>
<custom-meta>
<meta-name>Publication Update</meta-name>
<meta-value>2018-06-28</meta-value>
</custom-meta>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec001" sec-type="intro">
<title>Introduction</title>
<p>The traditional emphasis on complementarity between the drug and the catalytic site has inarguably formed a foundation in the current drug discovery approaches. However, many important drug targets share a conserved substrate binding site [<xref ref-type="bibr" rid="pcbi.1006228.ref001">1</xref>–<xref ref-type="bibr" rid="pcbi.1006228.ref005">5</xref>], rendering drug toxicity as a result of the off-target binding. The allosteric regulation of protein activity via effector binding has been increasingly favoured in the drug discovery [<xref ref-type="bibr" rid="pcbi.1006228.ref001">1</xref>, <xref ref-type="bibr" rid="pcbi.1006228.ref002">2</xref>, <xref ref-type="bibr" rid="pcbi.1006228.ref006">6</xref>]. It is well recognized that potentially druggable allosteric sites are ubiquitous in most if not all dynamic proteins [<xref ref-type="bibr" rid="pcbi.1006228.ref007">7</xref>], turning the key advantage of targeting allosteric sites [<xref ref-type="bibr" rid="pcbi.1006228.ref005">5</xref>]—non-competitive fine-tuning of protein activity at a distance—into a new paradigm in the drug design. For example, it was shown that allosteric drugs provide a way to modulating the activity of kinases that underlie a multitude of human diseases, bypassing the problem of low specificity with the conserved ATP binding pocket [<xref ref-type="bibr" rid="pcbi.1006228.ref008">8</xref>, <xref ref-type="bibr" rid="pcbi.1006228.ref009">9</xref>]. The allosteric drugs for GPCRs provide greater subtype selectivity among GPCR receptor families, while avoiding receptor desensitization typical for the orthosteric ones [<xref ref-type="bibr" rid="pcbi.1006228.ref010">10</xref>–<xref ref-type="bibr" rid="pcbi.1006228.ref012">12</xref>]. Currently, among the notable marketed drugs targeting GPCRs are cinacalcet [<xref ref-type="bibr" rid="pcbi.1006228.ref013">13</xref>] and maraviroc [<xref ref-type="bibr" rid="pcbi.1006228.ref014">14</xref>], an allosteric agonist for calcium-sensing receptor and an antiretroviral allosteric antagonist for the CCR5 receptor, respectively.</p>
<p>One of the major hurdles in the development of allosteric drugs lies in the finding of allosteric sites [<xref ref-type="bibr" rid="pcbi.1006228.ref005">5</xref>, <xref ref-type="bibr" rid="pcbi.1006228.ref015">15</xref>–<xref ref-type="bibr" rid="pcbi.1006228.ref017">17</xref>], for which a repertoire of experimental and computational methods is being developed. High-throughput fragment-based screening using a large chemical library formed the main thrust in the identification of potential allosteric sites and lead compounds in pharmaceutical research [<xref ref-type="bibr" rid="pcbi.1006228.ref018">18</xref>–<xref ref-type="bibr" rid="pcbi.1006228.ref020">20</xref>]. A number of site-directed approaches have been employed for detection and probing of allosteric sites and their modulatory effects, including disulfide trapping [<xref ref-type="bibr" rid="pcbi.1006228.ref021">21</xref>], alanine scanning [<xref ref-type="bibr" rid="pcbi.1006228.ref022">22</xref>], hydrogen-deuterium exchange mass spectrometry [<xref ref-type="bibr" rid="pcbi.1006228.ref023">23</xref>, <xref ref-type="bibr" rid="pcbi.1006228.ref024">24</xref>] and photoaffinity [<xref ref-type="bibr" rid="pcbi.1006228.ref025">25</xref>, <xref ref-type="bibr" rid="pcbi.1006228.ref026">26</xref>]. However, above experimental approaches while powerful, are relatively costly and time-consuming compared to any extensive analysis performed <italic>in silico</italic>. Computational approaches for finding the allosteric sites can be broadly classified as sequence-based and structure-based methods [<xref ref-type="bibr" rid="pcbi.1006228.ref003">3</xref>, <xref ref-type="bibr" rid="pcbi.1006228.ref004">4</xref>, <xref ref-type="bibr" rid="pcbi.1006228.ref027">27</xref>]. Sequence-based techniques utilize sequence homology inferred from the multiple sequence alignment to identify the co-evolving amino acids that constitute catalytic and allosteric sites [<xref ref-type="bibr" rid="pcbi.1006228.ref028">28</xref>]. However, complexity of the site-ligand interactions and energetics result in strong limitations on the predictive power of the sequence-based approaches [<xref ref-type="bibr" rid="pcbi.1006228.ref005">5</xref>, <xref ref-type="bibr" rid="pcbi.1006228.ref028">28</xref>, <xref ref-type="bibr" rid="pcbi.1006228.ref029">29</xref>]. Structure-based methods analyse binding pockets based on their topological and physicochemical features [<xref ref-type="bibr" rid="pcbi.1006228.ref005">5</xref>, <xref ref-type="bibr" rid="pcbi.1006228.ref030">30</xref>]. These approaches are strongly biased towards binding pockets that exhibit detectable curvature in the static 3D structure, in which case latent allosteric sites that can exist in a subset of a protein conformational ensemble may be left undetected.</p>
<p>We have recently introduced a structure-based perturbation model of allostery [<xref ref-type="bibr" rid="pcbi.1006228.ref031">31</xref>], which quantitatively describes the causality and energetics of allosteric communication, by simulating ligand binding as a local alteration in the protein inter-residue network of interactions. Because of the observation that perturbation at allosteric sites can affect distant functional site via modifying the energetics of the whole protein and assuming the reversibility of allosteric signalling, we hypothesized here that allosteric sites could be detected by perturbing the functional ones [<xref ref-type="bibr" rid="pcbi.1006228.ref005">5</xref>]. In order to test this hypothesis and to explore its predictive power, the reverse perturbation approach was developed here. Using a heterogeneous set of 13 classical allosteric proteins from previous studies [<xref ref-type="bibr" rid="pcbi.1006228.ref031">31</xref>–<xref ref-type="bibr" rid="pcbi.1006228.ref033">33</xref>], dubbed here the “classical set”, we found that perturbation at the functional sites allows one to identify known allosteric ones. In order to estimate the predictive power of reverse perturbation method, it was necessary to introduce an operational definition of the allosteric site in the framework of elastic network model of protein. Specifically, assuming that allosteric signalling occurs between non-overlapping distant sites, a distance condition was set to ensure communication and not direct physical interaction between residues of the functional and allosteric sites. Using the classical set and a new collection of 41 allosteric proteins from the benchmarking set [<xref ref-type="bibr" rid="pcbi.1006228.ref034">34</xref>], predictive power of the reverse perturbation method is shown. Furthermore, we argue that in addition to the widely addressed case of predicting latent allosteric sites [<xref ref-type="bibr" rid="pcbi.1006228.ref035">35</xref>], the task of inducing allosteric signalling with a desired and tunable level of agonistic/antagonistic activity can be naturally formulated. We show that the reverse perturbation approach opens the way for achieving above goal, allowing one to find targets for allosteric effectors and to optimize structures/compositions and interactions of corresponding regulatory site-effector pairs that will provide a desired allosteric response at the functional site.</p>
</sec>
<sec id="sec002" sec-type="results">
<title>Results</title>
<sec id="sec003">
<title>Identification of allosteric sites by the reverse perturbation approach</title>
<p>In the structure-based statistical mechanical model of allostery [<xref ref-type="bibr" rid="pcbi.1006228.ref031">31</xref>], ligand binding is modelled as a perturbation of the harmonic network associated with the protein. The perturbation is defined as a stiffening harmonic restraint applied to the residue pairs that compose the binding site of interest. As a result of the perturbation, residues in the binding site experience an increase of rigidity in comparison with the residues in the unperturbed binding site. We have shown that in the event of allosteric communication, the perturbation of the allosteric sites induces a response at the functional ones by altering their energetics and fluctuation dynamics [<xref ref-type="bibr" rid="pcbi.1006228.ref031">31</xref>]. Specifically, as a result of the perturbation in a binding site, a per-residue free energy change Δ<italic>g</italic><sub><italic>i</italic></sub> is obtained for each residue of the protein, which is the signature of the change in the amount of work exerted in the environment of residue <italic>i</italic>. Here we investigate the hypothesis of reversibility of allosteric communication, according to which one can detect a change in the free energy on the residues of allosteric sites when a perturbation–simulated binding–is applied in the functional sites (<xref ref-type="fig" rid="pcbi.1006228.g001">Fig 1</xref>).</p>
<fig id="pcbi.1006228.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pcbi.1006228.g001</object-id>
<label>Fig 1</label>
<caption>
<title>Reversing the allosteric communication leads to the identification of allosteric sites.</title>
<p>In allosteric communication, binding of effectors at allosteric sites causes a change of configurational work exerted in the distant functional sites. In the hypothesis of reversibility of allosteric communication, simulated ligand binding at the functional sites enables the identification of allosteric sites.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1006228.g001" xlink:type="simple"/>
</fig>
<p>To begin with, we analysed a set of classical allosteric proteins, dubbed here “classical set” [<xref ref-type="bibr" rid="pcbi.1006228.ref032">32</xref>, <xref ref-type="bibr" rid="pcbi.1006228.ref033">33</xref>], to directly test the hypothesis of the reverse perturbation approach in identifying allosteric sites in proteins of different sizes, oligomerization states and functions. <xref ref-type="table" rid="pcbi.1006228.t001">Table 1</xref> contains the average free energy changes (averaged over all residues in corresponding sites in case of oligomeric proteins) observed as a result of the allosteric signalling in known allosteric sites (Δ<italic>g</italic><sub><italic>A</italic></sub>) and in the restrained functional sites (Δ<italic>g</italic><sub><italic>F</italic></sub>) in 13 proteins of the classical set.</p>
<table-wrap id="pcbi.1006228.t001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pcbi.1006228.t001</object-id>
<label>Table 1</label> <caption><title>Free energy changes at the functional and allosteric sites upon reverse perturbation of the allosteric communication for the proteins of the classical set.</title></caption>
<alternatives>
<graphic id="pcbi.1006228.t001g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1006228.t001" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="center">Protein (#chain, #res)</th>
<th align="center">PDB ID</th>
<th align="center">Perturbation at functional site</th>
<th align="center">Δ<italic>g</italic><sub><italic>F</italic></sub> (<italic>kcal/mol</italic>)</th>
<th align="center">Allosteric Site (A/I)</th>
<th align="center">Δ<italic>g</italic><sub><italic>A</italic></sub> (<italic>kcal/mol</italic>)</th>
<th align="center">Δ<italic>g</italic><sub><italic>U</italic></sub> (<italic>kcal/mol</italic>)</th>
<th align="center">Proximity (%)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center">AnthS (2+2, 1426)</td>
<td align="center">1i7q</td>
<td align="center">2 × GLU</td>
<td align="center">-0.83</td>
<td align="center">TRP (I)</td>
<td align="center">0.42</td>
<td align="center">-0.29</td>
<td align="center">0</td>
</tr>
<tr>
<td align="center">ATCase (2×3+3×2, 2736)</td>
<td align="center">1d09</td>
<td align="center">6 × PAL</td>
<td align="center">-1.08</td>
<td align="center">ATP-CTP (A/I)</td>
<td align="center">1.75</td>
<td align="center">0.22</td>
<td align="center">0</td>
</tr>
<tr>
<td align="center">BGDH (6, 2976)</td>
<td align="center">1nr7</td>
<td align="center">6 × GLU/NDP</td>
<td align="center">-0.52<break/>-1.17</td>
<td align="center">ADP (A)<break/>GTP (I)</td>
<td align="center">0.18<break/>-0.18</td>
<td align="center">0.31</td>
<td align="center">3<break/>7</td>
</tr>
<tr>
<td align="center">CAP (2, 418)</td>
<td align="center">1o3q</td>
<td align="center">2 × DNA</td>
<td align="center">-1.11</td>
<td align="center">cAMP (A)</td>
<td align="center">1.73</td>
<td align="center">0.71</td>
<td align="center">0</td>
</tr>
<tr>
<td align="center">DAHPS (4, 1401)</td>
<td align="center">1kfl</td>
<td align="center">4 × PEP</td>
<td align="center">-0.19</td>
<td align="center">PHE (I)</td>
<td align="center">0.80</td>
<td align="center">0.15</td>
<td align="center">1</td>
</tr>
<tr>
<td align="center">DAK (2, 735)</td>
<td align="center">3ju5</td>
<td align="center">1 × ATP/ARG</td>
<td align="center">-1.92<break/>-0.75</td>
<td align="center">ATP (I)<break/>ARG (I)</td>
<td align="center">0.48<break/>1.01</td>
<td align="center">-0.01</td>
<td align="center">0</td>
</tr>
<tr>
<td align="center">G6PD (6, 1596)</td>
<td align="center">1cd5</td>
<td align="center">6 × AGP</td>
<td align="center">0.36</td>
<td align="center">16G (A)</td>
<td align="center">0.78</td>
<td align="center">0.66</td>
<td align="center">10</td>
</tr>
<tr>
<td align="center">NADME (4, 2232)</td>
<td align="center">1efk</td>
<td align="center">4 × NAD</td>
<td align="center">-0.82</td>
<td align="center">FUM (A)</td>
<td align="center">2.90</td>
<td align="center">0.67</td>
<td align="center">0</td>
</tr>
<tr>
<td align="center">PFK (4, 1284)</td>
<td align="center">3pfk</td>
<td align="center">4 × F6P/ADP</td>
<td align="center">0.43<break/>-0.63</td>
<td align="center">PEP (I)<break/>ADP (A)</td>
<td align="center">1.47<break/>1.35</td>
<td align="center">0.33</td>
<td align="center">0<break/>2</td>
</tr>
<tr>
<td align="center">PGDH (4, 1624)</td>
<td align="center">1yba</td>
<td align="center">4 × AKG/NAD</td>
<td align="center">-0.77<break/>-1.94</td>
<td align="center">SER (I)</td>
<td align="center">2.62</td>
<td align="center">0.01</td>
<td align="center">0</td>
</tr>
<tr>
<td align="center">PTP1B (1,278)</td>
<td align="center">2hnp</td>
<td align="center">1 × BPM</td>
<td align="center">-3.36</td>
<td align="center">892 (I)</td>
<td align="center">0.42</td>
<td align="center">-2.12</td>
<td align="center">0</td>
</tr>
<tr>
<td align="center">SSUPRT (4, 868)</td>
<td align="center">1xtu</td>
<td align="center">4 × UMP</td>
<td align="center">-0.73</td>
<td align="center">CTP (I)</td>
<td align="center">2.05</td>
<td align="center">-0.05</td>
<td align="center">1</td>
</tr>
<tr>
<td align="center">ThrS (2, 884)</td>
<td align="center">1e5x</td>
<td align="center">2 × PLP</td>
<td align="center">-3.06</td>
<td align="center">SAM (A)</td>
<td align="center">2.27</td>
<td align="center">0.05</td>
<td align="center">0</td>
</tr>
</tbody>
</table>
</alternatives>
</table-wrap>
<p>First column: Protein name, oligomerization state, and total number of residues. Second column: PDB ID of the protein. The third and fourth columns represent the perturbation applied to functional sites and the resulted Δ<italic>g</italic><sub><italic>F</italic></sub> values, respectively (see <xref ref-type="disp-formula" rid="pcbi.1006228.e055">Eq 7</xref> in Materials and Methods). The fifth and sixth columns show the known allosteric sites (A—allosteric activator, I—allosteric inhibitor) and the Δ<italic>g</italic><sub><italic>A</italic></sub> values in the allosteric sites in response to the reverse perturbation, respectively. The seventh column provides the average free energy differences Δ<italic>g</italic><sub><italic>U</italic></sub> over all the residues in the protein, giving an estimate on the protein stability changes caused by the applied perturbation. The last column gives the proximity between the corresponding functional and allosteric sites in a protein subunit (see <xref ref-type="disp-formula" rid="pcbi.1006228.e056">Eq 8</xref> in Materials and Methods).</p>
</sec>
<sec id="sec004">
<title>The set of classical allosteric proteins</title>
<p>The Anthranilate synthase (AnthS) from <italic>Serratia marcescens</italic> is a heterotetramer consisting of a dimer of TrpE and TrpG subunits. Upon perturbation of the glutamine substrate binding sites, the tryptophan (inhibitor) binding sites in the larger TrpE subunits show a positive free energy difference response (<inline-formula id="pcbi.1006228.e001"><alternatives><graphic id="pcbi.1006228.e001g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006228.e001" xlink:type="simple"/><mml:math display="inline" id="M1"><mml:mi mathvariant="normal">Δ</mml:mi><mml:msubsup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>T</mml:mi><mml:mi>R</mml:mi><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>2</mml:mn><mml:mo>×</mml:mo><mml:mi>G</mml:mi><mml:mi>L</mml:mi><mml:mi>U</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula> = 0.42 kcal/mol), compared to the overall decrease in the free energy of the structure and stabilization of the entire TrpG subunits upon perturbation (<inline-formula id="pcbi.1006228.e002"><alternatives><graphic id="pcbi.1006228.e002g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006228.e002" xlink:type="simple"/><mml:math display="inline" id="M2"><mml:mi mathvariant="normal">Δ</mml:mi><mml:msubsup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>A</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mi>h</mml:mi><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>2</mml:mn><mml:mo>×</mml:mo><mml:mi>G</mml:mi><mml:mi>L</mml:mi><mml:mi>U</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula> = -0.29 kcal/mol, <xref ref-type="fig" rid="pcbi.1006228.g002">Fig 2A</xref> and <xref ref-type="table" rid="pcbi.1006228.t001">Table 1</xref>).</p>
<fig id="pcbi.1006228.g002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pcbi.1006228.g002</object-id>
<label>Fig 2</label>
<caption>
<title>Free energy profiles obtained as a result of the reverse perturbation for AnthS, ATCase, CAP and DAHPS.</title>
<p>(A) AnthS, a heterotetramer involved in the biosynthesis of anthranilate. (B) ATCase, a heterododecamer that catalyzes the first step in pyrimidine biosynthesis. (C) CAP, a homodimeric transcriptional activator. (D) DAHPS, a homotetramer involved in the biosynthesis of aromatic amino acids. The free energy changes are the average from corresponding residues in different subunits. The symbols indicate residues in corresponding ligand binding sites. Grey error bands indicate the standard deviation of Δ<italic>g</italic><sub><italic>i</italic></sub> across the subunits. In the middle, the structure of the protein in the C<sub>α</sub> coarse-grained model is colored according to the free energy change (increased–blue, decreased–red). The tube radius is proportional to the value of the free energy change. Colored spheres indicate ligand binding sites in a simplified quaternary structure depicted on the right: red or orange colors are used for functional sites, blue–for allosteric sites.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1006228.g002" xlink:type="simple"/>
</fig>
<p>The aspartate carbamoyltransferase (ATCase, <xref ref-type="fig" rid="pcbi.1006228.g002">Fig 2B</xref>) from <italic>Escherichia coli</italic> is a heterododecameric enzyme composed of two trimers of catalytic subunits in the centre of the oligomer and three dimers of the peripheral regulatory subunits. Simulated binding in the catalytic sites of ATCase (PAL sites) increases the configurational work exerted at the allosteric domain in the regulatory subunits that contain allosteric activator ATP and inhibitor CTP (<inline-formula id="pcbi.1006228.e003"><alternatives><graphic id="pcbi.1006228.e003g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006228.e003" xlink:type="simple"/><mml:math display="inline" id="M3"><mml:mi mathvariant="normal">Δ</mml:mi><mml:msubsup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>A</mml:mi><mml:mi>T</mml:mi><mml:mi>P</mml:mi><mml:mo>−</mml:mo><mml:mi>C</mml:mi><mml:mi>T</mml:mi><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>6</mml:mn><mml:mo>×</mml:mo><mml:mi>P</mml:mi><mml:mi>A</mml:mi><mml:mi>L</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula> = 1.75 kcal/mol, <xref ref-type="table" rid="pcbi.1006228.t001">Table 1</xref>), but not the zinc-binding domain which plays a structural role in the complex assembly.</p>
<p>Allosterically activated by cyclic AMP, the catabolite activator protein (CAP) from <italic>E</italic>. <italic>coli</italic> is a classical model system of transcriptional activation. The cAMP binding causes large rotation in the DNA-binding domain of CAP, which is a prerequisite for interactions with DNA [<xref ref-type="bibr" rid="pcbi.1006228.ref036">36</xref>]. Negative cooperativity observed for the binding of second cAMP molecule was discussed earlier [<xref ref-type="bibr" rid="pcbi.1006228.ref031">31</xref>], and it was shown that mutations in the cAMP-binding pocket decreasing the affinity between CAP and cAMP enhance negative cooperativity [<xref ref-type="bibr" rid="pcbi.1006228.ref037">37</xref>]. Using the DNA-bound conformation of CAP, we simulated binding in the DNA interaction sites and observed that allosteric site in the N-terminal cAMP-binding domains exhibits a large positive free energy change (<inline-formula id="pcbi.1006228.e004"><alternatives><graphic id="pcbi.1006228.e004g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006228.e004" xlink:type="simple"/><mml:math display="inline" id="M4"><mml:mi mathvariant="normal">Δ</mml:mi><mml:msubsup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>c</mml:mi><mml:mi>A</mml:mi><mml:mi>M</mml:mi><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>2</mml:mn><mml:mo>×</mml:mo><mml:mi>D</mml:mi><mml:mi>N</mml:mi><mml:mi>A</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula> = 1.73 kcal/mol), higher than the average free energy change (<inline-formula id="pcbi.1006228.e005"><alternatives><graphic id="pcbi.1006228.e005g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006228.e005" xlink:type="simple"/><mml:math display="inline" id="M5"><mml:mi mathvariant="normal">Δ</mml:mi><mml:msubsup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:mi>A</mml:mi><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>2</mml:mn><mml:mo>×</mml:mo><mml:mi>D</mml:mi><mml:mi>N</mml:mi><mml:mi>A</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula> = 0.71 kcal/mol) of the homodimer (<xref ref-type="fig" rid="pcbi.1006228.g002">Fig 2C</xref> and <xref ref-type="table" rid="pcbi.1006228.t001">Table 1</xref>).</p>
<p>For the homotetrameric 3-deoxy-D-arabino-heptulosonate-7-phosphate synthase (DAHPS) from <italic>E</italic>.<italic>coli</italic>, binding of the phosphoenolpyruvate (PEP) substrate to the TIM barrel domain was simulated. We observed a positive free energy change (<inline-formula id="pcbi.1006228.e006"><alternatives><graphic id="pcbi.1006228.e006g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006228.e006" xlink:type="simple"/><mml:math display="inline" id="M6"><mml:mi mathvariant="normal">Δ</mml:mi><mml:msubsup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>P</mml:mi><mml:mi>H</mml:mi><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>4</mml:mn><mml:mo>×</mml:mo><mml:mi>P</mml:mi><mml:mi>E</mml:mi><mml:mi>P</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula> = 0.80 kcal/mol) in the center of the quaternary complex, where the inter-subunit pockets for allosteric inhibitor phenylalanine (PHE) are located, while the whole structure yields rather a modest positive free energy change (<inline-formula id="pcbi.1006228.e007"><alternatives><graphic id="pcbi.1006228.e007g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006228.e007" xlink:type="simple"/><mml:math display="inline" id="M7"><mml:mi mathvariant="normal">Δ</mml:mi><mml:msubsup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>D</mml:mi><mml:mi>A</mml:mi><mml:mi>H</mml:mi><mml:mi>P</mml:mi><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>4</mml:mn><mml:mo>×</mml:mo><mml:mi>P</mml:mi><mml:mi>H</mml:mi><mml:mi>E</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula> = 0.15 kcal/mol, <xref ref-type="fig" rid="pcbi.1006228.g002">Fig 2D</xref> and <xref ref-type="table" rid="pcbi.1006228.t001">Table 1</xref>).</p>
<p>The dimeric arginine kinase (DAK) from <italic>Apostichopus japonicus</italic> is known to exhibit negative cooperativity, in which binding of substrates (ARG and ATP) to one subunit causes a conformational change in the free subunit. Specifically, “large outward reorganization of the other subunit (open state) which result in the release of products”, that precludes substrate binding was experimentally observed [<xref ref-type="bibr" rid="pcbi.1006228.ref038">38</xref>]. We found that perturbing the catalytic sites in one subunit destabilizes the unperturbed one (<inline-formula id="pcbi.1006228.e008"><alternatives><graphic id="pcbi.1006228.e008g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006228.e008" xlink:type="simple"/><mml:math display="inline" id="M8"><mml:mi mathvariant="normal">Δ</mml:mi><mml:msubsup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>A</mml:mi><mml:mi>R</mml:mi><mml:mi>G</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>×</mml:mo><mml:mi>A</mml:mi><mml:mi>R</mml:mi><mml:mi>G</mml:mi><mml:mo>/</mml:mo><mml:mi>A</mml:mi><mml:mi>T</mml:mi><mml:mi>P</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula> = 1.01 kcal/mol and <inline-formula id="pcbi.1006228.e009"><alternatives><graphic id="pcbi.1006228.e009g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006228.e009" xlink:type="simple"/><mml:math display="inline" id="M9"><mml:mi mathvariant="normal">Δ</mml:mi><mml:msubsup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>A</mml:mi><mml:mi>T</mml:mi><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>×</mml:mo><mml:mi>A</mml:mi><mml:mi>R</mml:mi><mml:mi>G</mml:mi><mml:mo>/</mml:mo><mml:mi>A</mml:mi><mml:mi>T</mml:mi><mml:mi>P</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula> = 0.48 kcal/mol, <xref ref-type="fig" rid="pcbi.1006228.g003">Fig 3A</xref> and <xref ref-type="table" rid="pcbi.1006228.t001">Table 1</xref>), presumably reducing its affinity to substrates.</p>
<fig id="pcbi.1006228.g003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pcbi.1006228.g003</object-id>
<label>Fig 3</label>
<caption>
<title>Free energy profiles obtained as a result of the reverse perturbation for DAK, NADME, PFK and PGDH.</title>
<p>(A) DAK, a dimeric arginine kinase. (B) NADME, a homotetramer for oxidative decarboxylation of malate to pyruvate. (C) PFK, the homotetramer is a key enzyme in glycolytic pathway. (D) PGDH, a homotetramer involved in the biosynthesis of serine.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1006228.g003" xlink:type="simple"/>
</fig>
<p>The NAD binding sites in the Rossmann fold were perturbed in the human NAD-dependent malic enzyme (NADME). <xref ref-type="fig" rid="pcbi.1006228.g003">Fig 3B</xref> shows that configurational work propagates from the outer domains of the homotetramer to the dimerization interface where the allosteric activator fumarate (FUM) binds, increasing the amount of work exerted in these sites (<inline-formula id="pcbi.1006228.e010"><alternatives><graphic id="pcbi.1006228.e010g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006228.e010" xlink:type="simple"/><mml:math display="inline" id="M10"><mml:mi mathvariant="normal">Δ</mml:mi><mml:msubsup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>F</mml:mi><mml:mi>U</mml:mi><mml:mi>M</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>4</mml:mn><mml:mo>×</mml:mo><mml:mi>N</mml:mi><mml:mi>A</mml:mi><mml:mi>D</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula> = 2.90 kcal/mol) to a much larger extent than the overall free energy change (<inline-formula id="pcbi.1006228.e011"><alternatives><graphic id="pcbi.1006228.e011g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006228.e011" xlink:type="simple"/><mml:math display="inline" id="M11"><mml:mi mathvariant="normal">Δ</mml:mi><mml:msubsup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>N</mml:mi><mml:mi>A</mml:mi><mml:mi>D</mml:mi><mml:mi>M</mml:mi><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>4</mml:mn><mml:mo>×</mml:mo><mml:mi>N</mml:mi><mml:mi>A</mml:mi><mml:mi>D</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula> = 0.67 kcal/mol, <xref ref-type="fig" rid="pcbi.1006228.g003">Fig 3B</xref> and <xref ref-type="table" rid="pcbi.1006228.t001">Table 1</xref>). Noteworthy, latent allosteric sites could also exist in the extended area near the core of this quaternary complex where large positive configurational work is observed as a result of perturbation at the functional sites.</p>
<p>A classical allosteric enzyme with a long history of studies, the phosphofructokinase (PFK) from <italic>Bacillus stearothermophilus</italic>, is a homotetramer. When the substrate and cofactor binding sites for fructose-6-phosphate (F6P) and ATP were perturbed, the allosteric response at the regulatory exosites (that bind activator ADP and inhibitor phosphoenolpyruvate (PEP)) located in the dimerization interface is manifested in the increase of the free energy (<inline-formula id="pcbi.1006228.e012"><alternatives><graphic id="pcbi.1006228.e012g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006228.e012" xlink:type="simple"/><mml:math display="inline" id="M12"><mml:mi mathvariant="normal">Δ</mml:mi><mml:msubsup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>A</mml:mi><mml:mi>D</mml:mi><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>4</mml:mn><mml:mo>×</mml:mo><mml:mi>F</mml:mi><mml:mn>6</mml:mn><mml:mi>P</mml:mi><mml:mo>/</mml:mo><mml:mi>A</mml:mi><mml:mi>T</mml:mi><mml:mi>P</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula> = 1.35 kcal/mol and <inline-formula id="pcbi.1006228.e013"><alternatives><graphic id="pcbi.1006228.e013g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006228.e013" xlink:type="simple"/><mml:math display="inline" id="M13"><mml:mi mathvariant="normal">Δ</mml:mi><mml:msubsup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>P</mml:mi><mml:mi>E</mml:mi><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>4</mml:mn><mml:mo>×</mml:mo><mml:mi>F</mml:mi><mml:mn>6</mml:mn><mml:mi>P</mml:mi><mml:mo>/</mml:mo><mml:mi>A</mml:mi><mml:mi>T</mml:mi><mml:mi>P</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula> = 1.47 kcal/mol) detected in these sites, respectively (<xref ref-type="fig" rid="pcbi.1006228.g003">Fig 3C</xref> and <xref ref-type="table" rid="pcbi.1006228.t001">Table 1</xref>).</p>
<p>The D-3-phosphoglycerate dehydrogenase (PGDH) of <italic>E</italic>. <italic>coli</italic> is a homotetramer with a ring-shaped quaternary structure. Simulated binding at the substrate AKG and cofactor NAD sites, which are located in the interface between corresponding substrate and cofactor domains, allows one to identify the binding sites for allosteric inhibitor serine (SER) in the distant peripheral regulatory domains. The serine binding sites show a large positive free energy change (<inline-formula id="pcbi.1006228.e014"><alternatives><graphic id="pcbi.1006228.e014g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006228.e014" xlink:type="simple"/><mml:math display="inline" id="M14"><mml:mi mathvariant="normal">Δ</mml:mi><mml:msubsup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi><mml:mi>E</mml:mi><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>4</mml:mn><mml:mo>×</mml:mo><mml:mi>A</mml:mi><mml:mi>K</mml:mi><mml:mi>G</mml:mi><mml:mo>/</mml:mo><mml:mi>N</mml:mi><mml:mi>A</mml:mi><mml:mi>D</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula> = 2.62 kcal/mol) in comparison with the negligible background free energy increase (<xref ref-type="fig" rid="pcbi.1006228.g003">Fig 3D</xref> and <xref ref-type="table" rid="pcbi.1006228.t001">Table 1</xref>).</p>
<p>The overall change in the free energy of the small monomeric human protein tyrosine phosphatase 1B (PTP1B) is negative upon restraining the catalytic site BPM (<inline-formula id="pcbi.1006228.e015"><alternatives><graphic id="pcbi.1006228.e015g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006228.e015" xlink:type="simple"/><mml:math display="inline" id="M15"><mml:mi>Δ</mml:mi><mml:msubsup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>P</mml:mi><mml:mi>T</mml:mi><mml:mi>P</mml:mi><mml:mn>1</mml:mn><mml:mi>B</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>×</mml:mo><mml:mi>B</mml:mi><mml:mi>P</mml:mi><mml:mi>M</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula> = -2.12 kcal/mol), pointing to the strong stabilizing role of this perturbation. We observed a slight increase of the free energy at the known allosteric site 892 (<inline-formula id="pcbi.1006228.e016"><alternatives><graphic id="pcbi.1006228.e016g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006228.e016" xlink:type="simple"/><mml:math display="inline" id="M16"><mml:mi mathvariant="normal">Δ</mml:mi><mml:msubsup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mn>892</mml:mn></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>×</mml:mo><mml:mi>B</mml:mi><mml:mi>P</mml:mi><mml:mi>M</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula> = 0.42 kcal/mol, <xref ref-type="fig" rid="pcbi.1006228.g004">Fig 4A</xref> and <xref ref-type="table" rid="pcbi.1006228.t001">Table 1</xref>). Additionally, the beta sheet distant from the catalytic site exhibited large increase in the free energy change, suggesting the presence of a potential latent allosteric site (<xref ref-type="fig" rid="pcbi.1006228.g004">Fig 4A</xref>).</p>
<fig id="pcbi.1006228.g004" position="float">
<object-id pub-id-type="doi">10.1371/journal.pcbi.1006228.g004</object-id>
<label>Fig 4</label>
<caption>
<title>Free energy profiles obtained as a result of the reverse perturbation for PTP1B, SSUPRT and ThrS.</title>
<p>(A) PTP1B, a monomeric enzyme that regulates the insulin signalling pathway. (B) SSUPRT, a homotetramer that catalyzes the synthesis of uridine monophosphate. (C) ThrS, a homodimer for the biosynthesis of threonine.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1006228.g004" xlink:type="simple"/>
</fig>
<p>The uracil phosphoribosyltransferase from <italic>Sulfolobus solfataricus</italic> (SSUPRT) is a homotetramer that catalyzes the production of uridine 5′-monophosphate (UMP). As a result of perturbing the catalytic sites UMP in the outer regions (<xref ref-type="fig" rid="pcbi.1006228.g004">Fig 4B</xref>), residues in the binding site for the allosteric inhibitor CTP at the central interface show the positive free energy change (<inline-formula id="pcbi.1006228.e017"><alternatives><graphic id="pcbi.1006228.e017g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006228.e017" xlink:type="simple"/><mml:math display="inline" id="M17"><mml:mi mathvariant="normal">Δ</mml:mi><mml:msubsup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:mi>T</mml:mi><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>4</mml:mn><mml:mo>×</mml:mo><mml:mi>U</mml:mi><mml:mi>M</mml:mi><mml:mi>P</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula> = 2.05 kcal/mol, <xref ref-type="table" rid="pcbi.1006228.t001">Table 1</xref>) compared to the overall small average free energy change (<inline-formula id="pcbi.1006228.e018"><alternatives><graphic id="pcbi.1006228.e018g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006228.e018" xlink:type="simple"/><mml:math display="inline" id="M18"><mml:mi mathvariant="normal">Δ</mml:mi><mml:msubsup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi><mml:mi>S</mml:mi><mml:mi>U</mml:mi><mml:mi>P</mml:mi><mml:mi>R</mml:mi><mml:mi>T</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>4</mml:mn><mml:mo>×</mml:mo><mml:mi>U</mml:mi><mml:mi>M</mml:mi><mml:mi>P</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula> = -0.05 kcal/mol).</p>
<p>The homodimer of threonine synthase (ThrS) from <italic>Arabidopsis thaliana</italic> features an extensive interface between the subunits, in which the allosteric activator S-adenosylmethionine (SAM) binds. Similar to SSUPRT, when the protein’s catalytic sites pyridoxal-L-phosphate PLP are stabilized, the configurational work exerted on the binding sites for SAM increases (<inline-formula id="pcbi.1006228.e019"><alternatives><graphic id="pcbi.1006228.e019g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006228.e019" xlink:type="simple"/><mml:math display="inline" id="M19"><mml:mi mathvariant="normal">Δ</mml:mi><mml:msubsup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi><mml:mi>A</mml:mi><mml:mi>M</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>2</mml:mn><mml:mo>×</mml:mo><mml:mi>P</mml:mi><mml:mi>L</mml:mi><mml:mi>P</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula> = 2.27 kcal/mol, <xref ref-type="table" rid="pcbi.1006228.t001">Table 1</xref>) in contrast to the small average free energy change (<inline-formula id="pcbi.1006228.e020"><alternatives><graphic id="pcbi.1006228.e020g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006228.e020" xlink:type="simple"/><mml:math display="inline" id="M20"><mml:mi mathvariant="normal">Δ</mml:mi><mml:msubsup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>T</mml:mi><mml:mi>h</mml:mi><mml:mi>r</mml:mi><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>2</mml:mn><mml:mo>×</mml:mo><mml:mi>P</mml:mi><mml:mi>L</mml:mi><mml:mi>P</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula> = 0.05 kcal/mol, <xref ref-type="fig" rid="pcbi.1006228.g004">Fig 4C</xref>).</p>
<p>The bovine glutamate dehydrogenase (BGDH) and the glucosamine-6-phosphate deaminase (G6PD) from <italic>E</italic>.<italic>coli</italic>, are large homohexamers consisting of a dimer of trimers, and a trimer of dimers, respectively. The well-studied allosteric regulation of BGDH features a repertoire of metabolites as well as several characterized allosteric sites [<xref ref-type="bibr" rid="pcbi.1006228.ref039">39</xref>, <xref ref-type="bibr" rid="pcbi.1006228.ref040">40</xref>]. It is known that binding of glutamate (GLU) substrate and NADP+ (NDP) cofactor to the catalytic cleft elicits large-scale conformational changes in this complex molecular machine. For example, the antenna region (<xref ref-type="fig" rid="pcbi.1006228.g005">Fig 5A</xref>), which consists of intertwined alpha helices and is evolutionarily conserved in the animal kingdom, is essential to the allostery of BGDH. The antenna serves as the inter-subunit relay of allostery, and its motion is regulated by the allosteric activator ADP and inhibitor GTP. Remarkably, we observed the large increase in the free energy of allosteric response (5 kcal/mol) in the antenna region upon perturbation of the catalytic sites, in comparison to the small background free energy change (<inline-formula id="pcbi.1006228.e021"><alternatives><graphic id="pcbi.1006228.e021g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006228.e021" xlink:type="simple"/><mml:math display="inline" id="M21"><mml:mi>Δ</mml:mi><mml:msubsup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>B</mml:mi><mml:mi>G</mml:mi><mml:mi>D</mml:mi><mml:mi>H</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>6</mml:mn><mml:mo>×</mml:mo><mml:mi>G</mml:mi><mml:mi>L</mml:mi><mml:mi>U</mml:mi><mml:mo>/</mml:mo><mml:mi>N</mml:mi><mml:mi>D</mml:mi><mml:mi>P</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula> = 0.31 kcal/mol, <xref ref-type="fig" rid="pcbi.1006228.g005">Fig 5A</xref> and <xref ref-type="table" rid="pcbi.1006228.t001">Table 1</xref>). On the other hand, a weak response is detected in the ADP and GTP binding sites (<inline-formula id="pcbi.1006228.e022"><alternatives><graphic id="pcbi.1006228.e022g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006228.e022" xlink:type="simple"/><mml:math display="inline" id="M22"><mml:mi mathvariant="normal">Δ</mml:mi><mml:msubsup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>A</mml:mi><mml:mi>D</mml:mi><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>6</mml:mn><mml:mo>×</mml:mo><mml:mi>G</mml:mi><mml:mi>L</mml:mi><mml:mi>U</mml:mi><mml:mo>/</mml:mo><mml:mi>N</mml:mi><mml:mi>D</mml:mi><mml:mi>P</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula> = 0.18 kcal/mol and <inline-formula id="pcbi.1006228.e023"><alternatives><graphic id="pcbi.1006228.e023g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006228.e023" xlink:type="simple"/><mml:math display="inline" id="M23"><mml:mi mathvariant="normal">Δ</mml:mi><mml:msubsup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>G</mml:mi><mml:mi>T</mml:mi><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>6</mml:mn><mml:mo>×</mml:mo><mml:mi>G</mml:mi><mml:mi>L</mml:mi><mml:mi>U</mml:mi><mml:mo>/</mml:mo><mml:mi>N</mml:mi><mml:mi>D</mml:mi><mml:mi>P</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula> = -0.18 kcal/mol, <xref ref-type="table" rid="pcbi.1006228.t001">Table 1</xref>). The configurational work exerted in the antenna region is consistent with experimental data, which shows rotation of the helices as the bound catalytic cleft closes [<xref ref-type="bibr" rid="pcbi.1006228.ref039">39</xref>, <xref ref-type="bibr" rid="pcbi.1006228.ref040">40</xref>]. We found that, in agreement with experimental data in which the presence of antenna region was shown to be required for allosteric signalling, this region plays a role of the allosteric modulator, suggesting, in turn, the presence of latent allosteric sites in this region (<xref ref-type="fig" rid="pcbi.1006228.g005">Fig 5A</xref>).</p>
<fig id="pcbi.1006228.g005" position="float">
<object-id pub-id-type="doi">10.1371/journal.pcbi.1006228.g005</object-id>
<label>Fig 5</label>
<caption>
<title>Results of the reverse perturbation of allosteric communication in the large BGDH and G6PD homohexamers.</title>
<p>Reverse perturbation of the allosteric communication suggested the presence of latent allosteric sites in the antenna region of the BGDH (A) and various locations of the G6PD (B). The antenna region of BGDH and the Cys219 in the core of G6PD are highlighted by circles in the free energy profiles. The large standard deviation of the per-residue free energy change is caused by the structural asymmetry of homologous subunits.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1006228.g005" xlink:type="simple"/>
</fig>
<p>In the case of homohexameric G6PD (<xref ref-type="fig" rid="pcbi.1006228.g005">Fig 5B</xref>), the allosteric response results in the positive free energy change globally distributed in the complex upon perturbation in all catalytic sites (alpha-D-glucosamine 6-phosphate (AGP), <inline-formula id="pcbi.1006228.e024"><alternatives><graphic id="pcbi.1006228.e024g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006228.e024" xlink:type="simple"/><mml:math display="inline" id="M24"><mml:mi mathvariant="normal">Δ</mml:mi><mml:msubsup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>G</mml:mi><mml:mn>6</mml:mn><mml:mi>P</mml:mi><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>6</mml:mn><mml:mo>×</mml:mo><mml:mi>A</mml:mi><mml:mi>G</mml:mi><mml:mi>P</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula> = 0.66 kcal/mol), including the inter-subunit interface where the allosteric activator N-acetylglucosamine 6-phosphate (16G) binds (<inline-formula id="pcbi.1006228.e025"><alternatives><graphic id="pcbi.1006228.e025g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006228.e025" xlink:type="simple"/><mml:math display="inline" id="M25"><mml:mi mathvariant="normal">Δ</mml:mi><mml:msubsup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mn>16</mml:mn><mml:mi>G</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>6</mml:mn><mml:mo>×</mml:mo><mml:mi>A</mml:mi><mml:mi>G</mml:mi><mml:mi>P</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula> = 0.78 kcal/mol, <xref ref-type="table" rid="pcbi.1006228.t001">Table 1</xref>). In particular, residues at the core appeared to be highly affected by the perturbation, especially Cys219, which forms disulphide bridges between subunits. Perturbing the catalytic site of one subunit essentially freezes the entire subunit including the proximal allosteric site for the activator 16G, increasing the free energy in the remaining unperturbed subunits (<xref ref-type="supplementary-material" rid="pcbi.1006228.s008">S1 Fig</xref>). It was shown in X-ray crystallography [<xref ref-type="bibr" rid="pcbi.1006228.ref041">41</xref>] and fluorescence spectroscopy [<xref ref-type="bibr" rid="pcbi.1006228.ref042">42</xref>] experiments that the substrate binding to the catalytic site of G6PD induces structural and dynamic changes in all subunits of the protein, consistent with our observations.</p>
<p>The classical set of proteins analysed here contains an equal proportion of protein structures in the apo and bound forms. Using crystal structures of PFK and PGDH with or without bound ligands, we show that the free energy profiles are largely similar (<xref ref-type="supplementary-material" rid="pcbi.1006228.s002">S2</xref> and <xref ref-type="supplementary-material" rid="pcbi.1006228.s003">S3</xref> Figs), allowing to work with only one available structure. In all proteins of the classical set, a positive free energy difference was detected in distant allosteric sites upon perturbation of the substrate and/or cofactor binding, as well as an anticipated negative one in the regions where the perturbation is applied. Despite the different modes of allosteric regulation, binding sites for both allosteric activator and inhibitor exhibit an increase of configurational work exerted upon perturbation of the functional ones. For example, in enzymes with overlapping binding sites for activator and inhibitor, such as the ATCase (<xref ref-type="fig" rid="pcbi.1006228.g002">Fig 2B</xref>) and the PFK (<xref ref-type="fig" rid="pcbi.1006228.g003">Fig 3C</xref>), both sites show positive Δ<italic>g</italic><sub><italic>i</italic></sub> values. Therefore, the positive free energy difference as a result of the functional site perturbation serves in our approach as the standard quantitative indicator for the allosteric sites.</p>
<p>The profiles of the free energy changes due to the reverse allosteric signalling upon perturbation at the functional sites typically show rather extensive areas of the positive free energy difference, which encompass the binding sites of known allosteric effectors. Therefore, the locations that yield a large free energy change can, actually, be allosterically coupled to corresponding catalytic site, and, therefore, can potentially contain unknown/latent allosteric sites. For example, the reverse perturbation analysis suggests the presence of latent allosteric sites in the large TrpE subunit of AnthS (<xref ref-type="fig" rid="pcbi.1006228.g002">Fig 2A</xref>), in the cAMP-binding domain of CAP (<xref ref-type="fig" rid="pcbi.1006228.g002">Fig 2C</xref>), in PTP1B (<xref ref-type="fig" rid="pcbi.1006228.g004">Fig 4A</xref>), as well as in the dimerization interface in NADME (<xref ref-type="fig" rid="pcbi.1006228.g003">Fig 3B</xref>), PFK (<xref ref-type="fig" rid="pcbi.1006228.g003">Fig 3C</xref>) and ThrS (<xref ref-type="fig" rid="pcbi.1006228.g004">Fig 4C</xref>). Furthermore, the antenna region in BGDH (<xref ref-type="fig" rid="pcbi.1006228.g005">Fig 5A</xref>) and multiple locations in G6PD (<xref ref-type="fig" rid="pcbi.1006228.g005">Fig 5B</xref>) can also contain latent allosteric sites that provide complex allosteric regulation of these large protein complexes.</p>
</sec>
<sec id="sec005">
<title>Operational definition of an allosteric site in the framework of the elastic network model</title>
<p><xref ref-type="fig" rid="pcbi.1006228.g005">Fig 5</xref> shows two cases, BGDH and G6PD, in which it was not possible to identify known regulatory sites proximal to the perturbed catalytic ones. In these proteins, the perturbation of the catalytic site stabilizes the region proximal to the binding sites due to the direct interaction of residues in these adjacent sites. These cases show that the separation of allosteric and the regulated functional sites is instrumental in allosteric communication, as postulated in the seminal Monod-Changeux-Jacob paper [<xref ref-type="bibr" rid="pcbi.1006228.ref043">43</xref>] that allosteric proteins should “…possess two, or at least two, stereospecifically different, non-overlapping receptor sites.” Therefore, for any high-throughput analysis and prediction of regulatory exosites, it is crucial to introduce a quantitative measure for spatial separation between catalytic and allosteric sites.</p>
<p>Here, we have devised an operational definition of the allosteric site in the framework of the elastic network model of protein. To obtain a quantitative criterion for defining the allosteric site we introduce a notion of proximity, which is the fraction of interacting residues among all possible pairs that can be formed between residues of two sites–functional and the candidate allosteric ones. The distance cutoff for defining the interaction between residues is chosen according to the distance cutoff (11 Å) used in the microscopic allosteric potential of the original model [<xref ref-type="bibr" rid="pcbi.1006228.ref031">31</xref>] (see also <xref ref-type="sec" rid="sec009">Materials and Methods</xref>). Taking the most conservative approach, we have chosen the upper limit cutoff 11Å, which allows one to predict most of the allosteric sites. A site is considered allosteric if the corresponding proximity with the functional site does not exceed the threshold value (selection of the threshold value is explained below). We illustrate this definition by two homologous homotetramers, fructose 1,6-bisphosphatase 1 (FBPase 1) from <italic>E</italic>. <italic>coli</italic> (PDB ID: 2q8m, <xref ref-type="fig" rid="pcbi.1006228.g006">Fig 6A</xref>) and from <italic>Sus scrofa</italic> (PDB ID: 1kz8, <xref ref-type="fig" rid="pcbi.1006228.g006">Fig 6B</xref>), which control the gluconeogenesis pathway [<xref ref-type="bibr" rid="pcbi.1006228.ref044">44</xref>].</p>
<fig id="pcbi.1006228.g006" position="float">
<object-id pub-id-type="doi">10.1371/journal.pcbi.1006228.g006</object-id>
<label>Fig 6</label>
<caption>
<title>The operational definition of allosteric sites.</title>
<p>The homologous FBPase1 from (A) <italic>E</italic>. <italic>coli</italic> and (B) <italic>Sus scrofa</italic> are used for the illustration of the communication versus physical interactions between residues of functional and allosteric sites. Residues in ligand binding sites are indicated by spheres on the left. Pairs of residues in different sites, with C<sub>α</sub> pairwise distance not greater than 11 Å are shown by black lines. On the right, ligands from the ligand-bound crystal structures are superimposed to the analysed apo structures to show the location of the binding sites. Free energy changes of every residue upon reverse perturbation are calculated and displayed on the structures (colors and tube thickness) and in the free energy profiles.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1006228.g006" xlink:type="simple"/>
</fig>
<p>Adenosine monophosphate (AMP) and glucose-6-phosphate (BG6) bind to two distinct allosteric sites of FBPase 1 from <italic>E</italic>. <italic>coli</italic>, inhibiting hydrolysis of fructose 1,6-bisphosphate (FBP) [<xref ref-type="bibr" rid="pcbi.1006228.ref045">45</xref>]. The inhibitor binding at BG6 site would perturb the adjacent active FBP site via direct interaction between residues in these overlapping sites, whereas the distant AMP site regulates the FBP site by long-range allosteric signalling. Therefore, using the reverse perturbation approach, the distant AMP site can be readily identified based on the increase in free energy of allosteric response (<inline-formula id="pcbi.1006228.e026"><alternatives><graphic id="pcbi.1006228.e026g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006228.e026" xlink:type="simple"/><mml:math display="inline" id="M26"><mml:mi mathvariant="normal">Δ</mml:mi><mml:msubsup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>A</mml:mi><mml:mi>M</mml:mi><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>4</mml:mn><mml:mo>×</mml:mo><mml:mi>F</mml:mi><mml:mi>B</mml:mi><mml:mi>P</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula> = 1.67 kcal/mol). However, simulated binding in the FBP site (<inline-formula id="pcbi.1006228.e027"><alternatives><graphic id="pcbi.1006228.e027g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006228.e027" xlink:type="simple"/><mml:math display="inline" id="M27"><mml:mi mathvariant="normal">Δ</mml:mi><mml:msubsup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>F</mml:mi><mml:mi>B</mml:mi><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>4</mml:mn><mml:mo>×</mml:mo><mml:mi>F</mml:mi><mml:mi>B</mml:mi><mml:mi>P</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula> = -0.77 kcal/mol) decreases the free energy of the adjacent BG6 site (<inline-formula id="pcbi.1006228.e028"><alternatives><graphic id="pcbi.1006228.e028g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006228.e028" xlink:type="simple"/><mml:math display="inline" id="M28"><mml:mi mathvariant="normal">Δ</mml:mi><mml:msubsup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>B</mml:mi><mml:mi>G</mml:mi><mml:mn>6</mml:mn></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>4</mml:mn><mml:mo>×</mml:mo><mml:mi>F</mml:mi><mml:mi>B</mml:mi><mml:mi>P</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula> = -1.62 kcal/mol), which is not a true allosteric site because of the 10% proximity to the FBP site (<xref ref-type="fig" rid="pcbi.1006228.g006">Fig 6A</xref>). Non-allosteric nature of interactions between the BG6 and FBP sites can be further confirmed by the weak decrease of the free energy observed upon direct perturbation via simulated binding to BG6 (<inline-formula id="pcbi.1006228.e029"><alternatives><graphic id="pcbi.1006228.e029g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006228.e029" xlink:type="simple"/><mml:math display="inline" id="M29"><mml:mi mathvariant="normal">Δ</mml:mi><mml:msubsup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>F</mml:mi><mml:mi>B</mml:mi><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>2</mml:mn><mml:mo>×</mml:mo><mml:mi>B</mml:mi><mml:mi>G</mml:mi><mml:mn>6</mml:mn></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula> = -0.1 kcal/mol). On the contrary, the direct perturbation at the distant AMP (inhibitor) binding site increases the configurational work exerted at the FBP site (<inline-formula id="pcbi.1006228.e030"><alternatives><graphic id="pcbi.1006228.e030g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006228.e030" xlink:type="simple"/><mml:math display="inline" id="M30"><mml:mi mathvariant="normal">Δ</mml:mi><mml:msubsup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>F</mml:mi><mml:mi>B</mml:mi><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>4</mml:mn><mml:mo>×</mml:mo><mml:mi>A</mml:mi><mml:mi>M</mml:mi><mml:mi>P</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula> = 0.44 kcal/mol), yielding the allosteric nature of communication between these sites.</p>
<p>The drug screening against FBPase 1 from <italic>Sus scrofa</italic> revealed that one of the anilinoquinazoline compounds, PFE, inhibits gluconeogenesis by binding to an allosteric site at the subunit interface [<xref ref-type="bibr" rid="pcbi.1006228.ref046">46</xref>]. Upon perturbing the catalytic FBP site, both AMP and PFE sites (with 0 and 2% proximity to the FBP site, respectively), displayed a similar increase in the free energy (<inline-formula id="pcbi.1006228.e031"><alternatives><graphic id="pcbi.1006228.e031g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006228.e031" xlink:type="simple"/><mml:math display="inline" id="M31"><mml:mi mathvariant="normal">Δ</mml:mi><mml:msubsup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>A</mml:mi><mml:mi>M</mml:mi><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>4</mml:mn><mml:mo>×</mml:mo><mml:mi>F</mml:mi><mml:mi>B</mml:mi><mml:mi>P</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula> = 1.36 kcal/mol and <inline-formula id="pcbi.1006228.e032"><alternatives><graphic id="pcbi.1006228.e032g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006228.e032" xlink:type="simple"/><mml:math display="inline" id="M32"><mml:mi mathvariant="normal">Δ</mml:mi><mml:msubsup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>P</mml:mi><mml:mi>F</mml:mi><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>4</mml:mn><mml:mo>×</mml:mo><mml:mi>F</mml:mi><mml:mi>B</mml:mi><mml:mi>P</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula> = 1.45 kcal/mol, <xref ref-type="fig" rid="pcbi.1006228.g006">Fig 6B</xref>). The configurational work exerted at the PFE site shows that the low proximity between functional and allosteric sites is a necessary condition for the correct definition of the latter. Additional analysis of several proteins that result in both successes and failures in detection of allosteric sites have led to the following operational definition: a site is considered allosterically coupled to the regulated catalytic one if the proximity between them is no more than 2%. The sites’ proximities obtained for each protein in the classical set (<xref ref-type="table" rid="pcbi.1006228.t001">Table 1</xref>) show that all proteins have non-overlapping functional and allosteric sites except the BGDH and G6PD, where the proximities are 7 and 10%, respectively, hence failed to be detected as allosteric ones. This operational definition is important in order to correctly estimate the predictive power of reverse perturbation approach, allowing us to operate with proteins with different architectures and mutual locations of the functional and allosteric sites.</p>
</sec>
<sec id="sec006">
<title>Predictive power of the reverse perturbation analysis</title>
<p>With the set of allosteric sites obtained on the basis of above operational definition, one can analyse the predictive power of the reverse perturbation approach. A successful prediction of allosteric sites is possible if their residues will exhibit a large free energy change upon perturbation of the functional site. The receiver operating characteristic (ROC) curve is used here to quantify the proportion of true positive (those that belong to a known allosteric site) and false positive (those not belonging to a known allosteric site) among residues with a large free energy change, upon perturbation at the corresponding functional sites (see <xref ref-type="sec" rid="sec009">Materials and Methods</xref> for details). Using the classical set of allosteric proteins, we show that the true positive rate increases more rapidly than the false positive rate for most allosteric sites, indicating that the majority of residues of known allosteric sites (true positives) are indeed located near the positive tail of the Δ<italic>g</italic><sub><italic>i</italic></sub> distribution (<xref ref-type="fig" rid="pcbi.1006228.g007">Fig 7A</xref>).</p>
<fig id="pcbi.1006228.g007" position="float">
<object-id pub-id-type="doi">10.1371/journal.pcbi.1006228.g007</object-id>
<label>Fig 7</label>
<caption>
<title>Receiver operating characteristic (ROC) curves.</title>
<p>(A) High predictive power can be achieved for most allosteric proteins with distant functional and allosteric sites. (B) Allosteric sites for which low predictive powers are obtained. (C) A histogram of the area under the ROC curves (AUCs) for the detection of allosteric sites in proteins from the additional benchmark set of 41 proteins.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1006228.g007" xlink:type="simple"/>
</fig>
<p>The known allosteric sites in the NADME (<xref ref-type="fig" rid="pcbi.1006228.g003">Fig 3B</xref>), PGDH (<xref ref-type="fig" rid="pcbi.1006228.g003">Fig 3D</xref>) and SSUPRT (<xref ref-type="fig" rid="pcbi.1006228.g004">Fig 4B</xref>) can be precisely determined based on the large increase in the free energy. It is important to emphasize, however, that presence of latent allosteric sites challenges the task of validating the prediction of the known ones, as some of the residues belonging to these sites can be erroneously scored as false positives. For example, the residues that show a large increase in Δ<italic>g</italic><sub><italic>i</italic></sub> values in potential allosteric sites, such as the antenna region in the BGDH, turn out to be false positives. Good predictive power can be achieved for known allosteric sites in the ATCase (<xref ref-type="fig" rid="pcbi.1006228.g002">Fig 2B</xref>), DAHPS (<xref ref-type="fig" rid="pcbi.1006228.g002">Fig 2D</xref>), DAK (<xref ref-type="fig" rid="pcbi.1006228.g003">Fig 3A</xref>), PFK (<xref ref-type="fig" rid="pcbi.1006228.g003">Fig 3C</xref>) and ThrS (<xref ref-type="fig" rid="pcbi.1006228.g004">Fig 4C</xref>). However, for the AnthS (<xref ref-type="fig" rid="pcbi.1006228.g002">Fig 2A</xref>), CAP (<xref ref-type="fig" rid="pcbi.1006228.g002">Fig 2C</xref>) and PTP1B (<xref ref-type="fig" rid="pcbi.1006228.g004">Fig 4A</xref>), the ROC curves are close to the diagonal line, indicating low predictive power for the known allosteric sites in these proteins (<xref ref-type="fig" rid="pcbi.1006228.g007">Fig 7A</xref>). This is likely due to the pronounced increase in free energy over the protein domains caused by catalytic site perturbation, suggesting the presence of latent allosteric sites that contribute to the false positives. For DAK (<xref ref-type="fig" rid="pcbi.1006228.g003">Fig 3A</xref>), the ROC curves for ARG (<xref ref-type="fig" rid="pcbi.1006228.g007">Fig 7A</xref>) and ATP binding sites in the free subunit (<xref ref-type="fig" rid="pcbi.1006228.g007">Fig 7B</xref>) vary greatly as the former site exhibits a higher increase in free energy, allowing its detection as the allosteric site. In the BGDH (<xref ref-type="fig" rid="pcbi.1006228.g005">Fig 5A</xref>) and G6PD (<xref ref-type="fig" rid="pcbi.1006228.g005">Fig 5B</xref>), the regulatory exosites are too close to the restrained catalytic site, hence, not satisfying the aforementioned operational definition (<xref ref-type="fig" rid="pcbi.1006228.g006">Fig 6B</xref>).</p>
<p>To complement the classical set of 13 allosteric proteins, we have used the operational definition of allosteric sites to obtain 41 proteins with 48 unique experimentally-determined allosteric sites from the benchmarking set of allosteric proteins [<xref ref-type="bibr" rid="pcbi.1006228.ref034">34</xref>] (<xref ref-type="supplementary-material" rid="pcbi.1006228.s008">S1 Table</xref>). We calculated the free energy profile for each of these proteins upon simulated ligand binding at the functional site (<xref ref-type="supplementary-material" rid="pcbi.1006228.s004">S4 Fig</xref>). Similar to the classical set, the predictive power of the reverse perturbation approach was estimated for each protein in this heterogeneous additional set. The area under the ROC curves (AUC) indicates good predictive power of the method (<xref ref-type="fig" rid="pcbi.1006228.g007">Fig 7C</xref>), showing that reverse perturbation approach allows one to successfully detect the majority of known allosteric sites in the additional set.</p>
</sec>
<sec id="sec007">
<title>Inducing and fine-tuning allosteric response</title>
<p>In addition to the detection of known allosteric sites, the reverse perturbation approach delineates extended protein regions which are also characterized by the positive free energy change. This observation along with multiple indications of the presence of latent allosteric sites [<xref ref-type="bibr" rid="pcbi.1006228.ref005">5</xref>] in different proteins show that allosteric response can also be artificially induced by the interactions with rationally selected sets of residues belonging to latent or <italic>de novo</italic> designated allosteric sites. A classical allosteric enzyme, PFK (<xref ref-type="fig" rid="pcbi.1006228.g003">Fig 3C</xref>), which is regulated by the activator ADP and inhibitor PEP binding to the overlapping binding sites, serves as an excellent illustration that large difference in allosteric response can be caused by minor changes in the composition of an allosteric site (<xref ref-type="fig" rid="pcbi.1006228.g008">Fig 8</xref>). Specifically, ligand binding to the PEP site, which is a part of the larger ADP binding site results in a mild increase of free energy in the functional F6P site (<inline-formula id="pcbi.1006228.e033"><alternatives><graphic id="pcbi.1006228.e033g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006228.e033" xlink:type="simple"/><mml:math display="inline" id="M33"><mml:mi mathvariant="normal">Δ</mml:mi><mml:msubsup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>F</mml:mi><mml:mn>6</mml:mn><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>4</mml:mn><mml:mo>×</mml:mo><mml:mi>P</mml:mi><mml:mi>E</mml:mi><mml:mi>P</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula> = 0.30 kcal/mol) compared to the global free energy change of the homotetramer (<inline-formula id="pcbi.1006228.e034"><alternatives><graphic id="pcbi.1006228.e034g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006228.e034" xlink:type="simple"/><mml:math display="inline" id="M34"><mml:mi mathvariant="normal">Δ</mml:mi><mml:msubsup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>P</mml:mi><mml:mi>F</mml:mi><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>4</mml:mn><mml:mo>×</mml:mo><mml:mi>P</mml:mi><mml:mi>E</mml:mi><mml:mi>P</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula> = 0.10 kcal/mol). At the same time, a large increase in free energy is observed at F6P site upon simulated binding to ADP site (<inline-formula id="pcbi.1006228.e035"><alternatives><graphic id="pcbi.1006228.e035g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006228.e035" xlink:type="simple"/><mml:math display="inline" id="M35"><mml:mi mathvariant="normal">Δ</mml:mi><mml:msubsup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>F</mml:mi><mml:mn>6</mml:mn><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>4</mml:mn><mml:mo>×</mml:mo><mml:mi>A</mml:mi><mml:mi>D</mml:mi><mml:mi>P</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula> = 0.70 kcal/mol, <xref ref-type="fig" rid="pcbi.1006228.g008">Fig 8</xref>). The modes of regulation in PFK, along with many other allosteric enzymes with overlapped activator and inhibitor binding sites in the literature [<xref ref-type="bibr" rid="pcbi.1006228.ref005">5</xref>] (see also, for example, ATCase, <xref ref-type="fig" rid="pcbi.1006228.g002">Fig 2B</xref>), highlights the importance of tuning allosteric response by varying the binding site composition.</p>
<fig id="pcbi.1006228.g008" position="float">
<object-id pub-id-type="doi">10.1371/journal.pcbi.1006228.g008</object-id>
<label>Fig 8</label>
<caption>
<title>Allosteric signalling from overlapping activator/inhibitor binding sites in PFK.</title>
<p>Perturbation of the larger binding site ADP (activator, red) causes larger increase in free energy (0.70 kcal/mol) to F6P functional sites, compared to that (0.30 kcal/mol) obtained from the smaller site PEP (inhibitor, blue). Residues in the sites are displayed as spheres along with the residue numbers. ADP and PEP from ligand-bound crystal structures (PDB code: 4pfk and 6pfk, respectively) are superimposed on the structure for illustration. The common residues that bind both ligands are colored grey, residues that only bind ADP are colored red. The distance cutoff for interacting residues of PFK and corresponding ligands is 3.5 Å.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1006228.g008" xlink:type="simple"/>
</fig>
<p>We consider here as case studies, the subunit interfaces of the NADME (<xref ref-type="fig" rid="pcbi.1006228.g003">Fig 3B</xref>), ThrS (<xref ref-type="fig" rid="pcbi.1006228.g004">Fig 4C</xref>) and FBPase 1 (<xref ref-type="fig" rid="pcbi.1006228.g006">Fig 6A</xref>), which can apparently be used to induce a required allosteric response. In our model, an allosteric site consists of a set of residues whose perturbation results in the large free energy change in the corresponding functional site. In a given protein, to obtain a magnitude of regulation comparable with that of the native effectors, the allosteric response at the functional sites originating from the newly designated regulatory sites should be comparable with that obtained from known allosteric sites.</p>
<p>The homotetrameric NADME is allosterically activated by the binding of fumarate (FUM) at the dimerization interface, causing a slight decrease in free energy at the catalytic site (<inline-formula id="pcbi.1006228.e036"><alternatives><graphic id="pcbi.1006228.e036g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006228.e036" xlink:type="simple"/><mml:math display="inline" id="M36"><mml:mi mathvariant="normal">Δ</mml:mi><mml:msubsup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>N</mml:mi><mml:mi>A</mml:mi><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>4</mml:mn><mml:mo>×</mml:mo><mml:mi>F</mml:mi><mml:mi>U</mml:mi><mml:mi>M</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula> = -0.18 kcal/mol). Based on the reverse perturbation analysis in NADME (<xref ref-type="fig" rid="pcbi.1006228.g003">Fig 3B</xref>) and in order to illustrate the possibility to induce an allosteric response, four sites were putatively defined in the protein region corresponding to the increase of the free energy: site 1 (red) and site 2 (green) are located at the dimerization interface where fumarate binds, site 3 (yellow) is situated at the tetramerization interface where ATP binds to stabilize the functional tetrameric form of the enzyme [<xref ref-type="bibr" rid="pcbi.1006228.ref047">47</xref>], site 4 (cyan) is close to the tetramer’s core, and site 5 (magenta), which is located in the protein region with negligible free energy change is used as a negative control (<xref ref-type="fig" rid="pcbi.1006228.g009">Fig 9</xref>).</p>
<fig id="pcbi.1006228.g009" position="float">
<object-id pub-id-type="doi">10.1371/journal.pcbi.1006228.g009</object-id>
<label>Fig 9</label>
<caption>
<title>Inducing the allosteric response in the NADME.</title>
<p>Left: reverse perturbation of allosteric communication in the NADME revealed presence of the repertoire of potential latent allosteric sites. Right: sites 1–5 are perturbed and the resulted free energy changes at functional NAD site are tabulated. Site 5 serves as a negative control.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1006228.g009" xlink:type="simple"/>
</fig>
<p>We show that a range of allosteric responses can be induced upon simulated binding to sites 1–4 for different modulation of the catalytic activity. Perturbation of site 1 induces a stronger decrease of the free energy in the catalytic site (<inline-formula id="pcbi.1006228.e037"><alternatives><graphic id="pcbi.1006228.e037g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006228.e037" xlink:type="simple"/><mml:math display="inline" id="M37"><mml:mi mathvariant="normal">Δ</mml:mi><mml:msubsup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>N</mml:mi><mml:mi>A</mml:mi><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>4</mml:mn><mml:mo>×</mml:mo><mml:mi>s</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi><mml:mspace width="0.25em"/><mml:mn>1</mml:mn></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula> = -0.80 kcal/mol) than that of the native FUM allosteric site (-0.18 kcal/mol). Similar to the effect of the FUM–site binding, perturbation of site 2 (<inline-formula id="pcbi.1006228.e038"><alternatives><graphic id="pcbi.1006228.e038g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006228.e038" xlink:type="simple"/><mml:math display="inline" id="M38"><mml:mi mathvariant="normal">Δ</mml:mi><mml:msubsup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>N</mml:mi><mml:mi>A</mml:mi><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>4</mml:mn><mml:mo>×</mml:mo><mml:mi>s</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi><mml:mspace width="0.25em"/><mml:mn>2</mml:mn></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula> = -0.17 kcal/mol) and the site 3 (<inline-formula id="pcbi.1006228.e039"><alternatives><graphic id="pcbi.1006228.e039g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006228.e039" xlink:type="simple"/><mml:math display="inline" id="M39"><mml:mi mathvariant="normal">Δ</mml:mi><mml:msubsup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>N</mml:mi><mml:mi>A</mml:mi><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>4</mml:mn><mml:mo>×</mml:mo><mml:mi>s</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi><mml:mspace width="0.25em"/><mml:mn>3</mml:mn></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula> = -0.12 kcal/mol) causes a slight decrease in the free energy in the catalytic site. On the other hand, simulated binding to site 4 strongly increases the free energy in the functional site (<inline-formula id="pcbi.1006228.e040"><alternatives><graphic id="pcbi.1006228.e040g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006228.e040" xlink:type="simple"/><mml:math display="inline" id="M40"><mml:mi mathvariant="normal">Δ</mml:mi><mml:msubsup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>N</mml:mi><mml:mi>A</mml:mi><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>4</mml:mn><mml:mo>×</mml:mo><mml:mi>s</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi><mml:mspace width="0.25em"/><mml:mn>4</mml:mn></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula> = 0.86 kcal/mol). The reverse perturbation analysis has also detected areas that are not allosterically coupled to the catalytic site, indeed simulated binding in site 5 (chosen as a negative control) induces only weak response in the catalytic site (<inline-formula id="pcbi.1006228.e041"><alternatives><graphic id="pcbi.1006228.e041g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006228.e041" xlink:type="simple"/><mml:math display="inline" id="M41"><mml:mi mathvariant="normal">Δ</mml:mi><mml:msubsup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>N</mml:mi><mml:mi>A</mml:mi><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>4</mml:mn><mml:mo>×</mml:mo><mml:mi>s</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi><mml:mspace width="0.25em"/><mml:mn>5</mml:mn></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula> = 0.05 kcal/mol). The generic nature of inducing allosteric response on the basis of the reverse perturbation approach is further illustrated with examples of allosteric signalling of different modes and magnitudes obtained in the cases of FBPase 1 (<xref ref-type="supplementary-material" rid="pcbi.1006228.s005">S5 Fig</xref>) and ThrS (<xref ref-type="supplementary-material" rid="pcbi.1006228.s006">S6 Fig</xref>).</p>
<p>Above analysis shows that in addition to the quest for latent allosteric sites, a more general question about the inducing of desired allosteric response can be formulated. Using site 1 of NAD-dependent malic enzyme as a test case, we show that the response can be further fine-tuned to achieve the necessary modulation in the catalytic site by varying the site’s composition (<xref ref-type="fig" rid="pcbi.1006228.g010">Fig 10</xref>).</p>
<fig id="pcbi.1006228.g010" position="float">
<object-id pub-id-type="doi">10.1371/journal.pcbi.1006228.g010</object-id>
<label>Fig 10</label>
<caption>
<title>Fine-tuning of the allosteric response.</title>
<p>Fine-tuning of allosteric response at the NAD functional site of the NAD-dependent malic enzyme can be achieved by varying composition of the perturbed site 1. The free energy changes (kcal/mol) at the NAD functional site are shown. The black lines indicate possible structures of ligand frameworks that can interact with corresponding allosteric sites.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1006228.g010" xlink:type="simple"/>
</fig>
<p>Restricting perturbation of site 1 (blue) to a subset of residues (Leu118, Ala119, Gln122) substantially weakens the allosteric response (from -0.80 kcal/mol to -0.14 kcal/mol, <xref ref-type="fig" rid="pcbi.1006228.g010">Fig 10</xref>). Replacing Leu118 with the closest neighbours Gly117 and Ser121 recovers stronger allosteric signal (-0.67 kcal/mol and -1.06 kcal/mol, respectively, <xref ref-type="supplementary-material" rid="pcbi.1006228.s007">S7 Fig</xref>). Alternatively, considering the subset of residues Gln122, His125 and Ile126 (red) which produces an allosteric effect, which is comparable (-0.82 kcal/mol) to that induced by perturbing the whole site 1 (<xref ref-type="fig" rid="pcbi.1006228.g010">Fig 10</xref>). Allosteric signalling can also be fine-tuned to be weaker by replacing Gln122 with Ala119, Cys120 or Ser121, resulting in the allosteric responses -0.21 kcal/mol, -0.21 kcal/mol and -0.29 kcal/mol, respectively, at the regulated functional site (<xref ref-type="supplementary-material" rid="pcbi.1006228.s007">S7 Fig</xref>). Sites 1–5 are well separated from the distant NAD site with less than 2% proximity, which ensures the allosteric nature of signalling from these putatively designated sites.</p>
<p>Inducing and fine-tuning the allosteric response should be further complemented by the rational design or selection of allosteric effectors. For example, minimal sets of residues as the basis for targeted allosteric response (e.g. blue and red sets, <xref ref-type="fig" rid="pcbi.1006228.g010">Fig 10</xref> (left, bottom) and <xref ref-type="supplementary-material" rid="pcbi.1006228.s007">S7 Fig</xref>) can be incrementally changed residue-by-residue (<xref ref-type="fig" rid="pcbi.1006228.g010">Fig 10</xref>) in order to achieve required strength of the allosteric signal. Alternatively, one can explore the repertoire of all possible binding sites, adjusting them for a given lead ligand (combined red-blue sets, <xref ref-type="fig" rid="pcbi.1006228.g010">Fig 10</xref>, right).</p>
</sec>
</sec>
<sec id="sec008" sec-type="conclusions">
<title>Discussion</title>
<p>Allostery is a universal phenomenon where ligand-binding at a regulatory site causes a change in the ligand-affinity and/or activity at the coupled functional site [<xref ref-type="bibr" rid="pcbi.1006228.ref043">43</xref>]. Serious attempts to utilize the advantages of targeting allosteric sites instead of the orthosteric ones have only started in recent years, and the concept of allosteric drugs has since formed an important part in drug discovery [<xref ref-type="bibr" rid="pcbi.1006228.ref001">1</xref>, <xref ref-type="bibr" rid="pcbi.1006228.ref002">2</xref>, <xref ref-type="bibr" rid="pcbi.1006228.ref005">5</xref>, <xref ref-type="bibr" rid="pcbi.1006228.ref006">6</xref>]. Prediction of allosteric sites that can remotely regulate the dynamics at the functional site of interest has been shown to be a challenging task [<xref ref-type="bibr" rid="pcbi.1006228.ref005">5</xref>, <xref ref-type="bibr" rid="pcbi.1006228.ref015">15</xref>, <xref ref-type="bibr" rid="pcbi.1006228.ref016">16</xref>]. In this paper we test the hypothesis of the reversibility of allosteric communication, according to which the perturbation at the functional site results in a signal that propagates towards allosterically active protein regions. We show that in most of the cases reverse perturbation at functional sites causes an increase of the free energy in protein regions that are dynamically coupled to them, which were subsequently used for the detection of allosteric sites. In general, the topology of the protein plays a non-trivial role in the propagation of the allosteric signal, especially when protein activity is regulated by more than one effectors. Using the protein set consisting of 13 classical allosteric proteins and an independent benchmark set of 41 proteins, we show that known allosteric sites can indeed be identified by the reverse perturbation method. Good predictive power of the method was obtained in all proteins of both classical and benchmark sets when the allosteric sites are spatially separated from the functional ones according to the operational definition of allosteric site, which, in turn, is based on the original Monod-Changeux-Jacob’s formulation [<xref ref-type="bibr" rid="pcbi.1006228.ref043">43</xref>] of allostery and relationship between the functional and the regulatory exosites.</p>
<p>After showing that known allosteric sites can be detected via the reverse perturbation method, we addressed the question of the allosteric sites identification. Using the NAD-dependent malic enzyme as an example, we show that simulated binding to two putatively defined sites in the protein region obtained from the reverse perturbation method (sites 2 and 3) results in the allosteric response at the functional site similar to that caused by the native effector fumarate. Moreover, the prediction of allosteric sites from the protein regions obtained via the reverse perturbation method may result in multiple solutions. A repertoire of overlapping and non-overlapping sites can induce comparable allosteric signals upon binding to these sites. This redundancy, suggests that the practical task on the detection of known and prediction of latent allosteric sites can be turned into the general problem of how to induce and fine-tune an allosteric response. The case studies of NAD-dependent malic enzyme, threonine synthase, and fructose-1,6-bisphosphatase were used here to show that a range of allosteric responses can be induced upon simulated binding in sites putatively defined in the regions with increased free energy obtained via the reverse perturbation approach. For example, while simulated binding in the fumarate and putatively designated sites 1–3 of NAD-dependent malic enzyme result in a free energy decrease at the catalytic site, perturbation in site 4 strongly increases the free energy in the catalytic site. Two additional examples, FBPase 1 and ThrS, further illustrate the possibility to adopt the reverse perturbation method for inducing the allosteric response. Further, a presence of the overlapping sites of activators and inhibitors, such as ADP and PEP in PFK, ATP and CTP in ATCase and many others, calls for the fine tuning of the induced allosteric signalling via the rational design of the interactions between ligand and binding site. We exemplify the fine-tuning of the allosteric effect by varying the composition of a designated binding site 1 of NAD-dependent malic enzyme, which results in different levels of the catalytic activity modulation. In general, knowing the allosteric response in the functional sites upon binding of the native allosteric ligand, it is possible to select new allosteric sites and/or ligands that cause the same effect as the natural ones and, therefore, can be considered as new regulatory exosites. Further, an exhaustive calculation of the allosteric effect caused by every residue would be instrumental for rationally defining the candidate/potential allosteric sites in the absence of preliminary experimental data. The latter can be obtained in mutation experiments that measure the allosteric effects of residue-by-residue substitutions on the protein activity [<xref ref-type="bibr" rid="pcbi.1006228.ref048">48</xref>], providing thus a foundation for the experimental verification and further improvement of the computational model.</p>
<p>Despite two major limitations of the current structure-based perturbation model, the lack of sequence information, and the coarse-grained description of proteins on the basis of structure-based C<sub>α</sub> model, the reverse perturbation method should be regarded as a general strategy in finding and exploring allosteric sites. For example, a reverse perturbation-like strategy was used in a recent experimental work where hydrogen exchange mass spectroscopy method was used for characterizing the allosterically active regions of protein Hsp90 induced by the orthosteric binding [<xref ref-type="bibr" rid="pcbi.1006228.ref049">49</xref>]. It is important to note, that modularity of the structure-based perturbation model is instrumental for improving the accuracy of calculations, as it was done, for example, in Gehrig, S. <italic>et al</italic>. [<xref ref-type="bibr" rid="pcbi.1006228.ref050">50</xref>], where instead of using normal modes the slowest principal components (PCA) calculated from the MD trajectories were used for the calculations of the allosteric potential and the corresponding free energy derived in our model. However, increase of the accuracy by implementing the MD simulations will come at a price of the calculation speed. An alternative way of the model improvement would be via including the sequence dependence in the energy function, which preserves, at the same time, the model’s efficiency in terms of the high speed of calculations.</p>
<p>To conclude, the task of inducing and fine-tuning of allosteric response can be generalized and formulated in the following sequence of steps: (i) finding the potential regulatory exosites via reverse perturbation approach; (ii) optimizing the compositions/structures of the binding exosites that can induce a required allosteric signalling upon binding to them; (iii) selection of the appropriate ligands that interact with the chosen allosteric site with sufficient binding affinity; (iv) allocation of the regulatory exosites that provide required allosteric effect at the corresponding functional site in the case of pre-existing library of ligands. By exploring the possibility to detect known, finding latent, and designing new regulatory exosites and corresponding allosteric effectors, the reverse perturbation method introduced in this work provides a conceptual framework aimed at the optimization of the allosteric regulation of protein activity.</p>
</sec>
<sec id="sec009" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="sec010">
<title>Protein data set</title>
<p>We used here the set of 13 allosteric enzymes included in previous studies [<xref ref-type="bibr" rid="pcbi.1006228.ref031">31</xref>–<xref ref-type="bibr" rid="pcbi.1006228.ref033">33</xref>], which we refer to as the “classical set”. An additional set of 41 allosteric proteins with 48 experimentally-determined allosteric sites is obtained from the benchmarking collection of allosteric proteins ASBench [<xref ref-type="bibr" rid="pcbi.1006228.ref034">34</xref>]. In collecting above additional set, we applied the following requirements: (i) structures lacking information on functional sites, on parts of the structures, proteins that change the oligomerization state and structures in which regulation involves protein-protein interactions were omitted together with other cases of missing annotation; (ii) based on the operational definition of the allosteric site and applying the “proximity threshold” (see below) of no more than 2%, we obtained the final list of 48 sites in 41 proteins (<xref ref-type="supplementary-material" rid="pcbi.1006228.s001">S1 Table</xref>). Interacting residues were extracted from the structures, based on the distance cutoff of 4.5 Å between the heavy atoms of protein residues and those of the ligand. The quaternary structure assemblies were obtained from the PDBePISA [<xref ref-type="bibr" rid="pcbi.1006228.ref051">51</xref>, <xref ref-type="bibr" rid="pcbi.1006228.ref052">52</xref>] with all water molecules, ions and ligands removed. The apo form of protein complexes was used whenever available, except for CAP due to the large structural difference between its apo and DNA-bound forms.</p>
</sec>
<sec id="sec011">
<title>Structure-based statistical mechanical model of allostery</title>
<p>The structure-based statistical mechanical model of allostery used in this work consists of three parts, which are described in detail in a previous work [<xref ref-type="bibr" rid="pcbi.1006228.ref031">31</xref>]. First, C<sub>α</sub> harmonic models are built for the ligand-free (unperturbed) and ligand-bound (perturbed) systems from a single crystal structure. The presence of a bound ligand, i.e. perturbation, is modeled via the harmonic restrain of all residue pairs in the binding site. For the unperturbed system, the harmonic potential for all pairs of C<sub>α</sub> atoms <italic>i</italic> and <italic>j</italic> is given by
<disp-formula id="pcbi.1006228.e042">
<alternatives>
<graphic id="pcbi.1006228.e042g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006228.e042" xlink:type="simple"/>
<mml:math display="block" id="M42">
<mml:mrow><mml:msup><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>0</mml:mn></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:msup><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi mathvariant="bold-italic">r</mml:mi><mml:mo>−</mml:mo><mml:msup><mml:mrow><mml:mi mathvariant="bold-italic">r</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msup></mml:mrow><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mrow><mml:mstyle displaystyle="true"><mml:munder><mml:mo>∑</mml:mo><mml:mrow><mml:mi>p</mml:mi><mml:mi>a</mml:mi><mml:mi>i</mml:mi><mml:mi>r</mml:mi><mml:mi>s</mml:mi><mml:mspace width="0.25em"/><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:munder></mml:mstyle><mml:mrow><mml:msub><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:msubsup><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msubsup></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:mrow>
</mml:math>
</alternatives>
<label>(1)</label>
</disp-formula>
where <bold><italic>r</italic></bold> is the 3N-dimensional vector of coordinates of C<sub>α</sub> atoms and <bold><italic>r</italic></bold><sup>0</sup> is a vector of C<sub>α</sub> atoms from the reference structure. The <italic>d</italic><sub><italic>i</italic>,<italic>j</italic></sub> is the distance between any pair of C<sub>α</sub> atoms <italic>i</italic> and <italic>j</italic>, the corresponding distance in the reference structure is <inline-formula id="pcbi.1006228.e043"><alternatives><graphic id="pcbi.1006228.e043g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006228.e043" xlink:type="simple"/><mml:math display="inline" id="M43"><mml:msubsup><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula>. The distance-dependent force constant <italic>k</italic><sub><italic>i</italic>,<italic>j</italic></sub> decays as <inline-formula id="pcbi.1006228.e044"><alternatives><graphic id="pcbi.1006228.e044g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006228.e044" xlink:type="simple"/><mml:math display="inline" id="M44"><mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mo>/</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msubsup></mml:mrow></mml:mrow></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mn>6</mml:mn></mml:mrow></mml:msup></mml:math></alternatives></inline-formula> with a global cutoff of 25 Å [<xref ref-type="bibr" rid="pcbi.1006228.ref053">53</xref>]. The potential associated with the ligand-bound state (B) with <italic>n</italic> bound sites <italic>S</italic> = {<italic>s</italic><sub>1</sub>,<italic>s</italic><sub>2</sub>,…,<italic>s</italic><sub><italic>n</italic></sub>} is given by
<disp-formula id="pcbi.1006228.e045">
<alternatives>
<graphic id="pcbi.1006228.e045g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006228.e045" xlink:type="simple"/>
<mml:math display="block" id="M45">
<mml:mrow><mml:msup><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>B</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:msup><mml:mspace width="0.25em"/><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi mathvariant="bold-italic">r</mml:mi><mml:mo>−</mml:mo><mml:msup><mml:mrow><mml:mi mathvariant="bold-italic">r</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msup></mml:mrow><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:msup><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>0</mml:mn></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:msup><mml:mspace width="0.25em"/><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi mathvariant="bold-italic">r</mml:mi><mml:mo>−</mml:mo><mml:msup><mml:mrow><mml:mi mathvariant="bold-italic">r</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msup></mml:mrow><mml:mo stretchy="false">)</mml:mo><mml:mo>+</mml:mo><mml:mi>α</mml:mi><mml:mrow><mml:mstyle displaystyle="true"><mml:munder><mml:mo>∑</mml:mo><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:munder></mml:mstyle><mml:mrow><mml:mrow><mml:mstyle displaystyle="true"><mml:munder><mml:mo>∑</mml:mo><mml:mrow><mml:mi>p</mml:mi><mml:mi>a</mml:mi><mml:mi>i</mml:mi><mml:mi>r</mml:mi><mml:mi>s</mml:mi><mml:mspace width="0.25em"/><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi><mml:mo>∈</mml:mo><mml:msub><mml:mrow><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:munder></mml:mstyle><mml:mrow><mml:msub><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:msubsup><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msubsup></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:mrow></mml:mrow></mml:mrow>
</mml:math>
</alternatives>
<label>(2)</label>
</disp-formula>
where <italic>α</italic> = 100 is a stiffening factor of the perturbed site. Protein’s configurational ensembles are characterized by the first 10 slowest normal modes <inline-formula id="pcbi.1006228.e046"><alternatives><graphic id="pcbi.1006228.e046g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006228.e046" xlink:type="simple"/><mml:math display="inline" id="M46"><mml:msubsup><mml:mrow><mml:mi mathvariant="bold-italic">e</mml:mi></mml:mrow><mml:mrow><mml:mi>μ</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>0</mml:mn></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula> and <inline-formula id="pcbi.1006228.e047"><alternatives><graphic id="pcbi.1006228.e047g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006228.e047" xlink:type="simple"/><mml:math display="inline" id="M47"><mml:msubsup><mml:mrow><mml:mi mathvariant="bold-italic">e</mml:mi></mml:mrow><mml:mrow><mml:mi>μ</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>B</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula> for the free and ligand-bound systems, respectively. Previous studies have shown that the conformational transitions in allosteric communication are well described by the first 10 low frequency normal modes [<xref ref-type="bibr" rid="pcbi.1006228.ref032">32</xref>, <xref ref-type="bibr" rid="pcbi.1006228.ref033">33</xref>].</p>
<p>Second, we define a microscopic allosteric potential associated with a residue <italic>i</italic>
<disp-formula id="pcbi.1006228.e048">
<alternatives>
<graphic id="pcbi.1006228.e048g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006228.e048" xlink:type="simple"/>
<mml:math display="block" id="M48">
<mml:mrow><mml:msub><mml:mrow><mml:mi>U</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:mfrac><mml:mrow><mml:munder><mml:mo stretchy="false">∑</mml:mo><mml:mrow><mml:mi>μ</mml:mi></mml:mrow></mml:munder><mml:mrow><mml:msub><mml:mrow><mml:mi>ε</mml:mi></mml:mrow><mml:mrow><mml:mi>μ</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:msubsup><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mi>μ</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:mrow></mml:mrow><mml:mo>,</mml:mo></mml:mrow>
</mml:math>
</alternatives>
<label>(3)</label>
</disp-formula>
which measures the total elastic work acting on a residue <italic>i</italic> as a result of the change in displacements of all its neighbours caused by the normal mode <italic>μ</italic>. The generic configuration of residue <italic>i</italic> is obtained from the reference configuration <inline-formula id="pcbi.1006228.e049"><alternatives><graphic id="pcbi.1006228.e049g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006228.e049" xlink:type="simple"/><mml:math display="inline" id="M49"><mml:msubsup><mml:mrow><mml:mi mathvariant="bold-italic">r</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula> by superimposing the vectors <bold><italic>e</italic></bold><sub><italic>μ</italic>,<italic>i</italic></sub> such as <inline-formula id="pcbi.1006228.e050"><alternatives><graphic id="pcbi.1006228.e050g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006228.e050" xlink:type="simple"/><mml:math display="inline" id="M50"><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">r</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>(</mml:mo><mml:mi>σ</mml:mi><mml:mo>)</mml:mo><mml:mo>=</mml:mo><mml:msubsup><mml:mrow><mml:mi mathvariant="bold-italic">r</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msubsup><mml:mo>+</mml:mo><mml:mrow><mml:msub><mml:mo stretchy="false">∑</mml:mo><mml:mrow><mml:mi>μ</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:msub><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mi>μ</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">e</mml:mi></mml:mrow><mml:mrow><mml:mi>μ</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>, where <italic>σ</italic> = (<italic>σ</italic><sub>1</sub>,…,<italic>σ</italic><sub><italic>μ</italic></sub>,…) is a vector of Gaussian amplitudes. Thus, the residue configuration <bold><italic>r</italic></bold><sub><italic>i</italic></sub>(<italic>σ</italic>) is uniquely identified by the state vector (<italic>σ</italic><sub>1</sub>,…,<italic>σ</italic><sub><italic>μ</italic></sub>,…). The parameters <italic>ε</italic><sub><italic>μ</italic>,<italic>i</italic></sub> measures the elastic stress on the residue <italic>i</italic> and its neighbours <italic>j</italic> as result of the motion associated with the mode <bold><italic>e</italic></bold><sub><italic>μ</italic></sub>
<disp-formula id="pcbi.1006228.e051">
<alternatives>
<graphic id="pcbi.1006228.e051g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006228.e051" xlink:type="simple"/>
<mml:math display="block" id="M51">
<mml:mrow><mml:msub><mml:mrow><mml:mi>ε</mml:mi></mml:mrow><mml:mrow><mml:mi>μ</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mrow><mml:mstyle displaystyle="true"><mml:munder><mml:mo>∑</mml:mo><mml:mrow><mml:mi>j</mml:mi><mml:mo>:</mml:mo><mml:msubsup><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msubsup><mml:mo>&lt;</mml:mo><mml:msub><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>c</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:munder></mml:mstyle><mml:mrow><mml:mi>c</mml:mi><mml:msup><mml:mrow><mml:mo>|</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">e</mml:mi></mml:mrow><mml:mrow><mml:mi>μ</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">e</mml:mi></mml:mrow><mml:mrow><mml:mi>μ</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>|</mml:mo></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow><mml:mo>,</mml:mo></mml:mrow>
</mml:math>
</alternatives>
<label>(4)</label>
</disp-formula>
where <italic>c</italic> = 1 kcal/mol/Å<sup>2</sup> and a distance cutoff <italic>d</italic><sub><italic>c</italic></sub> = 11 Å. The allosteric potential in <xref ref-type="disp-formula" rid="pcbi.1006228.e048">Eq 3</xref> is evaluated for both protein states, ligand free (0) and ligand bound (B) ones, respectively. Finally, in order to obtain a per-residue free energy, the allosteric potential is integrated over all possible configurations <italic>σ</italic>, resulting in the partition function <inline-formula id="pcbi.1006228.e052"><alternatives><graphic id="pcbi.1006228.e052g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006228.e052" xlink:type="simple"/><mml:math display="inline" id="M52"><mml:msub><mml:mrow><mml:mi>z</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="normal">Π</mml:mi></mml:mrow><mml:mrow><mml:mi>μ</mml:mi></mml:mrow></mml:msub><mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:mn>2</mml:mn><mml:mi>π</mml:mi><mml:msub><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi>B</mml:mi></mml:mrow></mml:msub><mml:mi>T</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>ε</mml:mi></mml:mrow><mml:mrow><mml:mi>μ</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>/</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:math></alternatives></inline-formula>, and, consecutively in the free energy <italic>g</italic><sub><italic>i</italic></sub> = −<italic>k</italic><sub><italic>B</italic></sub><italic>T</italic> ln <italic>z</italic><sub><italic>i</italic></sub>. The per-residue free energy difference between the unperturbed (0) and perturbed (B) protein states is
<disp-formula id="pcbi.1006228.e053">
<alternatives>
<graphic id="pcbi.1006228.e053g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006228.e053" xlink:type="simple"/>
<mml:math display="block" id="M53">
<mml:mrow><mml:mi>Δ</mml:mi><mml:msub><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:mfrac><mml:msub><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi>B</mml:mi></mml:mrow></mml:msub><mml:mi>T</mml:mi><mml:mrow><mml:mstyle displaystyle="true"><mml:munder><mml:mo>∑</mml:mo><mml:mrow><mml:mi>μ</mml:mi></mml:mrow></mml:munder></mml:mstyle><mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant="normal">ln</mml:mi></mml:mrow><mml:mrow><mml:mfrac><mml:mrow><mml:msubsup><mml:mrow><mml:mi>ε</mml:mi></mml:mrow><mml:mrow><mml:mi>μ</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>B</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:msubsup></mml:mrow><mml:mrow><mml:msubsup><mml:mrow><mml:mi>ε</mml:mi></mml:mrow><mml:mrow><mml:mi>μ</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>0</mml:mn></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:msubsup></mml:mrow></mml:mfrac></mml:mrow></mml:mrow></mml:mrow></mml:mrow><mml:mo>.</mml:mo></mml:mrow>
</mml:math>
</alternatives>
<label>(5)</label>
</disp-formula>
To compare the relative strength of the free energy change <italic>Δg</italic><sub><italic>i</italic></sub> for one residue to the effects on the corresponding subunit, the following average is considered
<disp-formula id="pcbi.1006228.e054">
<alternatives>
<graphic id="pcbi.1006228.e054g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006228.e054" xlink:type="simple"/>
<mml:math display="block" id="M54">
<mml:mrow><mml:mi>Δ</mml:mi><mml:msub><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>U</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>U</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mrow><mml:mstyle displaystyle="true"><mml:munder><mml:mo>∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>∈</mml:mo><mml:mi>U</mml:mi></mml:mrow></mml:munder></mml:mstyle><mml:mrow><mml:mi>Δ</mml:mi><mml:msub><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow><mml:mo>,</mml:mo></mml:mrow>
</mml:math>
</alternatives>
<label>(6)</label>
</disp-formula>
where <italic>n</italic><sub><italic>U</italic></sub> is the total number of residues in the subunit <italic>U</italic>.</p>
</sec>
<sec id="sec012">
<title>Reverse perturbation analysis</title>
<p>In the reverse perturbation approach, the functional sites are perturbed, and, as a result, the change in the free energy at the levels of residues and sites is evaluated throughout the protein. To analyse the Δ<italic>g</italic><sub><italic>i</italic></sub> values of every residue in the oligomeric enzyme and to obtain the corresponding Δ<italic>g</italic><sub><italic>i</italic></sub> profile, the Δ<italic>g</italic><sub><italic>i</italic></sub> of corresponding residues from different subunits are averaged. Both functional and allosteric sites are indicated on the Δ<italic>g</italic><sub><italic>i</italic></sub> profile (Figs <xref ref-type="fig" rid="pcbi.1006228.g002">2</xref>–<xref ref-type="fig" rid="pcbi.1006228.g006">6</xref> and <xref ref-type="supplementary-material" rid="pcbi.1006228.s008">S1</xref>–<xref ref-type="supplementary-material" rid="pcbi.1006228.s004">S4</xref> Figs). The change of the free energy in the site <italic>s</italic> is also estimated as the average of the free energy changes among the residues in this site
<disp-formula id="pcbi.1006228.e055">
<alternatives>
<graphic id="pcbi.1006228.e055g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006228.e055" xlink:type="simple"/>
<mml:math display="block" id="M55">
<mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi><mml:msub><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mrow><mml:mstyle displaystyle="true"><mml:munder><mml:mo>∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>∈</mml:mo><mml:mi>s</mml:mi></mml:mrow></mml:munder></mml:mstyle><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi><mml:msub><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow><mml:mo>,</mml:mo></mml:mrow>
</mml:math>
</alternatives>
<label>(7)</label>
</disp-formula>
where <italic>n</italic><sub><italic>s</italic></sub> is the total number of residues in the site <italic>s</italic>. <xref ref-type="disp-formula" rid="pcbi.1006228.e055">Eq 7</xref> is used to obtain the free energy changes for every functional and allosteric site.</p>
</sec>
<sec id="sec013">
<title>Operational definition of the allosteric site</title>
<p>The operational definition of the allosteric site is based on the restriction on a spatial proximity of communicating functional and regulatory sites. For every pair of residues <italic>i</italic> and <italic>j</italic>, the number of physically interacting pairs on the basis of the distance cutoff <italic>d</italic><sub><italic>c</italic></sub> = 11 Å is obtained. The proximity is defined as the fraction of interacting pairs over the total number of pairs between the residues of functional and candidate allosteric sites under consideration:
<disp-formula id="pcbi.1006228.e056">
<alternatives>
<graphic id="pcbi.1006228.e056g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006228.e056" xlink:type="simple"/>
<mml:math display="block" id="M56">
<mml:mrow><mml:mi>P</mml:mi><mml:mi>X</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>&lt;</mml:mo><mml:msub><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>c</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>×</mml:mo><mml:mn>100</mml:mn><mml:mi>%</mml:mi></mml:mrow>
</mml:math>
</alternatives>
<label>(8)</label>
</disp-formula>
A ligand-binding site is defined as allosteric for the corresponding functional site within the same subunit if the proximity <italic>PX</italic> is no more than 2%.</p>
</sec>
<sec id="sec014">
<title>Receiver operating characteristic curve (ROC) analysis</title>
<p>A distribution of the free energy changes Δ<italic>g</italic><sub><italic>i</italic></sub> is obtained upon perturbation of the catalytic sites for each protein in the classical and benchmark sets. For most of the allosteric proteins, all residues in the known allosteric sites exhibit an increase in the free energy, hence only the positive range of the Δ<italic>g</italic><sub><italic>i</italic></sub> distribution is used. In the PTP1B and BGDH, the entire Δ<italic>g</italic><sub><italic>i</italic></sub> distributions are used as the known allosteric sites contain equal proportion of residues with gain or loss of the free energy. For plotting the ROC, the first bin corresponding to the residues within the top 5% of the Δ<italic>g</italic><sub><italic>i</italic></sub> distribution is first used. A sequence of bins with decreasing thresholds with a 5% step is defined to obtain a series of true and false positive rates of the ROC curve. For residues with Δ<italic>g</italic><sub><italic>i</italic></sub> above the threshold, a true positive is scored if the residue in the crystal structure is located within 4.5 Å from the allosteric effector, whereas a false positive indicates that the residue does not belong to a known allosteric site.</p>
</sec>
<sec id="sec015">
<title>Computational framework and illustration</title>
<p>The harmonic models of proteins and the normal modes analysis are performed using the MMTK package [<xref ref-type="bibr" rid="pcbi.1006228.ref054">54</xref>]. Fourier approximation is used in the calculation of normal modes [<xref ref-type="bibr" rid="pcbi.1006228.ref055">55</xref>]. UCSF Chimera [<xref ref-type="bibr" rid="pcbi.1006228.ref056">56</xref>] is used to generate the illustrations.</p>
</sec>
</sec>
<sec id="sec016">
<title>Supporting information</title>
<supplementary-material id="pcbi.1006228.s001" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1006228.s001" xlink:type="simple">
<label>S1 Fig</label>
<caption>
<title>Reverse perturbation of a single functional site in glucosamine-6-phosphate deaminase.</title>
<p>Restraining the functional AGP site in glucosamine-6-phosphate deaminase (G6PD) stabilizes the entire protein subunit.</p>
<p>(TIFF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pcbi.1006228.s002" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1006228.s002" xlink:type="simple">
<label>S2 Fig</label>
<caption>
<title>Free energy profiles for different apo and ligand-bound structures of PFK.</title>
<p>Free energy profiles are calculated for the apo structure of PFK (PDB: 3pfk), the PFK structure with activator ADP and F6P bound (PDB: 4pfk) and the bound form of PFK with an inhibitor PEP (PDB: 6pfk).</p>
<p>(TIFF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pcbi.1006228.s003" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1006228.s003" xlink:type="simple">
<label>S3 Fig</label>
<caption>
<title>Free energy profiles for different apo and ligand-bound structures of PGDH.</title>
<p>For PGDH, AKG and NAD bound structure (PDB: 1yba) and SER bound structure (PDB: 1psd) are used.</p>
<p>(TIFF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pcbi.1006228.s004" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1006228.s004" xlink:type="simple">
<label>S4 Fig</label>
<caption>
<title>Free energy profiles for 41 allosteric proteins from the benchmark set.</title>
<p>Residues of the explored functional and allosteric sites are marked by different shapes and colors.</p>
<p>(PDF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pcbi.1006228.s005" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1006228.s005" xlink:type="simple">
<label>S5 Fig</label>
<caption>
<title>Inducing the allosteric response in fructose 1,6-phosphatase 1.</title>
<p>Reverse perturbation of allosteric communication reveals a repertoire of potential latent allosteric sites in the subunit interfaces of fructose 1,6-phosphatase (FBPase 1). Sites 1–3 in FBPase 1 are perturbed, and the resulted free energy changes at functional FBP site are tabulated. Site 4 serves as a negative control.</p>
<p>(TIFF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pcbi.1006228.s006" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1006228.s006" xlink:type="simple">
<label>S6 Fig</label>
<caption>
<title>Inducing the allosteric response in threonine synthase.</title>
<p>Reverse perturbation of allosteric communication reveals a repertoire of potential latent allosteric sites in the subunit interfaces of threonine synthase (ThrS). Sites 1–3 in ThrS are perturbed, and the resulted free energy changes at functional PLP sites are tabulated. Site 4 serves as a negative control.</p>
<p>(TIFF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pcbi.1006228.s007" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1006228.s007" xlink:type="simple">
<label>S7 Fig</label>
<caption>
<title>Fine-tuning of the allosteric response in NAD-dependent malic enzyme.</title>
<p>The compositions of red and blue subsites in the site 1 of NAD-dependent malic enzyme (NADME) are varied on a residue-by-residue basis for the fine-tuning of allosteric response exerted at the functional NAD site.</p>
<p>(TIFF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pcbi.1006228.s008" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1006228.s008" xlink:type="simple">
<label>S1 Table</label>
<caption>
<title>A list of 41 allosteric proteins with 48 allosteric sites obtained from the ASBench database [<xref ref-type="bibr" rid="pcbi.1006228.ref034">34</xref>].</title>
<p>The list is obtained on the basis of the operational definition of allosteric sites. Predictive power for known allosteric sites in the protein, which is quantified by the area under the ROC curves (AUCs) for positive free energies, is given in the last column.</p>
<p>(DOCX)</p>
</caption>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<p>We thank Lauren Booth (Australian National University) for her help with collecting the extended set of allosteric proteins during her internship in the group.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="pcbi.1006228.ref001"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wenthur</surname> <given-names>C. J.</given-names></name>, <name name-style="western"><surname>Gentry</surname> <given-names>P. R.</given-names></name>, <name name-style="western"><surname>Mathews</surname> <given-names>T. P.</given-names></name> &amp; <name name-style="western"><surname>Lindsley</surname> <given-names>C. W.</given-names></name> <article-title>Drugs for Allosteric Sites on Receptors</article-title>. <source>Annu. Rev. Pharmacol. Toxicol</source>. <volume>54</volume>, <fpage>165</fpage>–<lpage>184</lpage> (<year>2014</year>). <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1146/annurev-pharmtox-010611-134525" xlink:type="simple">10.1146/annurev-pharmtox-010611-134525</ext-link></comment> <object-id pub-id-type="pmid">24111540</object-id></mixed-citation></ref>
<ref id="pcbi.1006228.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nussinov</surname> <given-names>R.</given-names></name> &amp; <name name-style="western"><surname>Tsai</surname> <given-names>C.-J.</given-names></name> <article-title>Allostery in Disease and in Drug Discovery</article-title>. <source>Cell</source> <volume>153</volume>, <fpage>293</fpage>–<lpage>305</lpage> (<year>2013</year>). <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cell.2013.03.034" xlink:type="simple">10.1016/j.cell.2013.03.034</ext-link></comment> <object-id pub-id-type="pmid">23582321</object-id></mixed-citation></ref>
<ref id="pcbi.1006228.ref003"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lu</surname> <given-names>S.</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>S.</given-names></name> &amp; <name name-style="western"><surname>Zhang</surname> <given-names>J.</given-names></name> <article-title>Harnessing allostery: a novel approach to drug discovery</article-title>. <source>Med. Res. Rev</source>. <volume>34</volume>, <fpage>1242</fpage>–<lpage>1285</lpage> (<year>2014</year>). <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/med.21317" xlink:type="simple">10.1002/med.21317</ext-link></comment> <object-id pub-id-type="pmid">24827416</object-id></mixed-citation></ref>
<ref id="pcbi.1006228.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lu</surname> <given-names>S.</given-names></name>, <name name-style="western"><surname>Huang</surname> <given-names>W.</given-names></name> &amp; <name name-style="western"><surname>Zhang</surname> <given-names>J.</given-names></name> <article-title>Recent computational advances in the identification of allosteric sites in proteins</article-title>. <source>Drug Discov. Today</source> <volume>19</volume>, <fpage>1595</fpage>–<lpage>1600</lpage> (<year>2014</year>). <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.drudis.2014.07.012" xlink:type="simple">10.1016/j.drudis.2014.07.012</ext-link></comment> <object-id pub-id-type="pmid">25107670</object-id></mixed-citation></ref>
<ref id="pcbi.1006228.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Guarnera</surname> <given-names>E.</given-names></name> &amp; <name name-style="western"><surname>Berezovsky</surname> <given-names>I. N.</given-names></name> <article-title>Allosteric sites: remote control in regulation of protein activity</article-title>. <source>Curr. Opin. Struct. Biol</source>. <volume>37</volume>, <fpage>1</fpage>–<lpage>8</lpage> (<year>2016</year>). <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.sbi.2015.10.004" xlink:type="simple">10.1016/j.sbi.2015.10.004</ext-link></comment> <object-id pub-id-type="pmid">26562539</object-id></mixed-citation></ref>
<ref id="pcbi.1006228.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Berezovsky</surname> <given-names>I. N.</given-names></name> <article-title>Thermodynamics of allostery paves a way to allosteric drugs</article-title>. <source>Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics</source> <volume>1834</volume>, <fpage>830</fpage>–<lpage>835</lpage> (<year>2013</year>).</mixed-citation></ref>
<ref id="pcbi.1006228.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gunasekaran</surname> <given-names>K.</given-names></name>, <name name-style="western"><surname>Ma</surname> <given-names>B.</given-names></name> &amp; <name name-style="western"><surname>Nussinov</surname> <given-names>R.</given-names></name> <article-title>Is allostery an intrinsic property of all dynamic proteins?</article-title> <source>Proteins</source> <volume>57</volume>, <fpage>433</fpage>–<lpage>443</lpage> (<year>2004</year>). <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/prot.20232" xlink:type="simple">10.1002/prot.20232</ext-link></comment> <object-id pub-id-type="pmid">15382234</object-id></mixed-citation></ref>
<ref id="pcbi.1006228.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fang</surname> <given-names>Z.</given-names></name>, <name name-style="western"><surname>Grütter</surname> <given-names>C.</given-names></name> &amp; <name name-style="western"><surname>Rauh</surname> <given-names>D.</given-names></name> <article-title>Strategies for the selective regulation of kinases with allosteric modulators: exploiting exclusive structural features</article-title>. <source>ACS Chem. Biol</source>. <volume>8</volume>, <fpage>58</fpage>–<lpage>70</lpage> (<year>2013</year>). <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1021/cb300663j" xlink:type="simple">10.1021/cb300663j</ext-link></comment> <object-id pub-id-type="pmid">23249378</object-id></mixed-citation></ref>
<ref id="pcbi.1006228.ref009"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Knight</surname> <given-names>J. D. R.</given-names></name>, <name name-style="western"><surname>Qian</surname> <given-names>B.</given-names></name>, <name name-style="western"><surname>Baker</surname> <given-names>D.</given-names></name> &amp; <name name-style="western"><surname>Kothary</surname> <given-names>R.</given-names></name> <article-title>Conservation, variability and the modeling of active protein kinases</article-title>. <source>PLoS One</source> <volume>2</volume>, <fpage>e982</fpage> (<year>2007</year>). <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0000982" xlink:type="simple">10.1371/journal.pone.0000982</ext-link></comment> <object-id pub-id-type="pmid">17912359</object-id></mixed-citation></ref>
<ref id="pcbi.1006228.ref010"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wootten</surname> <given-names>D.</given-names></name>, <name name-style="western"><surname>Christopoulos</surname> <given-names>A.</given-names></name> &amp; <name name-style="western"><surname>Sexton</surname> <given-names>P. M.</given-names></name> <article-title>Emerging paradigms in GPCR allostery: implications for drug discovery</article-title>. <source>Nat. Rev. Drug Discov</source>. <volume>12</volume>, <fpage>630</fpage>–<lpage>644</lpage> (<year>2013</year>). <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nrd4052" xlink:type="simple">10.1038/nrd4052</ext-link></comment> <object-id pub-id-type="pmid">23903222</object-id></mixed-citation></ref>
<ref id="pcbi.1006228.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>May</surname> <given-names>L.</given-names></name>, <name name-style="western"><surname>Avlani</surname> <given-names>V.</given-names></name>, <name name-style="western"><surname>Sexton</surname> <given-names>P.</given-names></name> &amp; <name name-style="western"><surname>Christopoulos</surname> <given-names>A.</given-names></name> <article-title>Allosteric Modulation of G Protein-Coupled Receptors</article-title>. <source>Curr. Pharm. Des</source>. <volume>10</volume>, <fpage>2003</fpage>–<lpage>2013</lpage> (<year>2004</year>). <object-id pub-id-type="pmid">15279541</object-id></mixed-citation></ref>
<ref id="pcbi.1006228.ref012"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Conn</surname> <given-names>P. J.</given-names></name>, <name name-style="western"><surname>Christopoulos</surname> <given-names>A.</given-names></name> &amp; <name name-style="western"><surname>Lindsley</surname> <given-names>C. W.</given-names></name> <article-title>Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders</article-title>. <source>Nat. Rev. Drug Discov</source>. <volume>8</volume>, <fpage>41</fpage>–<lpage>54</lpage> (<year>2009</year>). <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nrd2760" xlink:type="simple">10.1038/nrd2760</ext-link></comment> <object-id pub-id-type="pmid">19116626</object-id></mixed-citation></ref>
<ref id="pcbi.1006228.ref013"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Harrington</surname> <given-names>P. E.</given-names></name> &amp; <name name-style="western"><surname>Fotsch</surname> <given-names>C.</given-names></name> <article-title>Calcium sensing receptor activators: calcimimetics</article-title>. <source>Curr. Med. Chem</source>. <volume>14</volume>, <fpage>3027</fpage>–<lpage>3034</lpage> (<year>2007</year>). <object-id pub-id-type="pmid">18220738</object-id></mixed-citation></ref>
<ref id="pcbi.1006228.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dorr</surname> <given-names>P.</given-names></name> <etal>et al</etal>. <article-title>Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity</article-title>. <source>Antimicrob. Agents Chemother</source>. <volume>49</volume>, <fpage>4721</fpage>–<lpage>4732</lpage> (<year>2005</year>). <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/AAC.49.11.4721-4732.2005" xlink:type="simple">10.1128/AAC.49.11.4721-4732.2005</ext-link></comment> <object-id pub-id-type="pmid">16251317</object-id></mixed-citation></ref>
<ref id="pcbi.1006228.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Song</surname> <given-names>K.</given-names></name> <etal>et al</etal>. <article-title>Improved Method for the Identification and Validation of Allosteric Sites</article-title>. <source>J. Chem. Inf. Model</source>. <volume>57</volume>, <fpage>2358</fpage>–<lpage>2363</lpage> (<year>2017</year>). <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1021/acs.jcim.7b00014" xlink:type="simple">10.1021/acs.jcim.7b00014</ext-link></comment> <object-id pub-id-type="pmid">28825477</object-id></mixed-citation></ref>
<ref id="pcbi.1006228.ref016"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lu</surname> <given-names>S.</given-names></name>, <name name-style="western"><surname>Ji</surname> <given-names>M.</given-names></name>, <name name-style="western"><surname>Ni</surname> <given-names>D.</given-names></name> &amp; <name name-style="western"><surname>Zhang</surname> <given-names>J.</given-names></name> <article-title>Discovery of hidden allosteric sites as novel targets for allosteric drug design</article-title>. <source>Drug Discov. Today</source> (<year>2017</year>). <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.drudis.2017.10.001" xlink:type="simple">10.1016/j.drudis.2017.10.001</ext-link></comment> <object-id pub-id-type="pmid">29030241</object-id></mixed-citation></ref>
<ref id="pcbi.1006228.ref017"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bastolla</surname> <given-names>U.</given-names></name> <article-title>Computing protein dynamics from protein structure with elastic network models</article-title>. <source>Wiley Interdiscip. Rev. Comput. Mol. Sci</source>. <volume>4</volume>, <fpage>488</fpage>–<lpage>503</lpage> (<year>2014</year>).</mixed-citation></ref>
<ref id="pcbi.1006228.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Macarron</surname> <given-names>R.</given-names></name> <etal>et al</etal>. <article-title>Impact of high-throughput screening in biomedical research</article-title>. <source>Nat. Rev. Drug Discov</source>. <volume>10</volume>, <fpage>188</fpage>–<lpage>195</lpage> (<year>2011</year>). <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nrd3368" xlink:type="simple">10.1038/nrd3368</ext-link></comment> <object-id pub-id-type="pmid">21358738</object-id></mixed-citation></ref>
<ref id="pcbi.1006228.ref019"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Surade</surname> <given-names>S.</given-names></name> <etal>et al</etal>. <article-title>A structure-guided fragment-based approach for the discovery of allosteric inhibitors targeting the lipophilic binding site of transcription factor EthR</article-title>. <source>Biochem. J</source> <volume>458</volume>, <fpage>387</fpage>–<lpage>394</lpage> (<year>2014</year>). <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1042/BJ20131127" xlink:type="simple">10.1042/BJ20131127</ext-link></comment> <object-id pub-id-type="pmid">24313835</object-id></mixed-citation></ref>
<ref id="pcbi.1006228.ref020"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bertekap</surname> <given-names>R. L.</given-names></name>, <name name-style="western"><surname>Burford</surname> <given-names>N. T</given-names> <suffix>Jr</suffix></name>., <name name-style="western"><surname>Li</surname> <given-names>Z</given-names></name>. &amp; <name name-style="western"><surname>Alt</surname> <given-names>A</given-names></name>. <article-title>High-Throughput Screening for Allosteric Modulators of GPCRs</article-title>. <source>Methods Mol. Biol</source>. <volume>1335</volume>, <fpage>223</fpage>–<lpage>240</lpage> (<year>2015</year>). <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/978-1-4939-2914-6_15" xlink:type="simple">10.1007/978-1-4939-2914-6_15</ext-link></comment> <object-id pub-id-type="pmid">26260604</object-id></mixed-citation></ref>
<ref id="pcbi.1006228.ref021"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sadowsky</surname> <given-names>J. D.</given-names></name> <etal>et al</etal>. <article-title>Turning a protein kinase on or off from a single allosteric site via disulfide trapping</article-title>. <source>Proceedings of the National Academy of Sciences</source> <volume>108</volume>, <fpage>6056</fpage>–<lpage>6061</lpage> (<year>2011</year>).</mixed-citation></ref>
<ref id="pcbi.1006228.ref022"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Boehlein</surname> <given-names>S. K.</given-names></name>, <name name-style="western"><surname>Shaw</surname> <given-names>J. R.</given-names></name>, <name name-style="western"><surname>Hannah</surname> <given-names>L. C.</given-names></name> &amp; <name name-style="western"><surname>Stewart</surname> <given-names>J. D.</given-names></name> <article-title>Probing Allosteric Binding Sites of the Maize Endosperm ADP-Glucose Pyrophosphorylase</article-title>. <source>Plant Physiol</source>. <volume>152</volume>, <fpage>85</fpage>–<lpage>95</lpage> (<year>2009</year>). <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1104/pp.109.146928" xlink:type="simple">10.1104/pp.109.146928</ext-link></comment> <object-id pub-id-type="pmid">19889875</object-id></mixed-citation></ref>
<ref id="pcbi.1006228.ref023"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Badireddy</surname> <given-names>S.</given-names></name> <etal>et al</etal>. <article-title>Cyclic AMP analog blocks kinase activation by stabilizing inactive conformation: conformational selection highlights a new concept in allosteric inhibitor design</article-title>. <source>Mol. Cell. Proteomics</source> <volume>10</volume>, <fpage>M110</fpage>.004390 (<year>2011</year>).</mixed-citation></ref>
<ref id="pcbi.1006228.ref024"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Krishnamurthy</surname> <given-names>S.</given-names></name>, <name name-style="western"><surname>Tulsian</surname> <given-names>N. K.</given-names></name>, <name name-style="western"><surname>Chandramohan</surname> <given-names>A.</given-names></name> &amp; <name name-style="western"><surname>Anand</surname> <given-names>G. S.</given-names></name> <article-title>Parallel Allostery by cAMP and PDE Coordinates Activation and Termination Phases in cAMP Signaling</article-title>. <source>Biophys. J</source>. <volume>109</volume>, <fpage>1251</fpage>–<lpage>1263</lpage> (<year>2015</year>). <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.bpj.2015.06.067" xlink:type="simple">10.1016/j.bpj.2015.06.067</ext-link></comment> <object-id pub-id-type="pmid">26276689</object-id></mixed-citation></ref>
<ref id="pcbi.1006228.ref025"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Magnaghi</surname> <given-names>P.</given-names></name> <etal>et al</etal>. <article-title>Covalent and allosteric inhibitors of the ATPase VCP/p97 induce cancer cell death</article-title>. <source>Nat. Chem. Biol</source>. <volume>9</volume>, <fpage>548</fpage>–<lpage>556</lpage> (<year>2013</year>). <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nchembio.1313" xlink:type="simple">10.1038/nchembio.1313</ext-link></comment> <object-id pub-id-type="pmid">23892893</object-id></mixed-citation></ref>
<ref id="pcbi.1006228.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pozdnyakov</surname> <given-names>N.</given-names></name> <etal>et al</etal>. <article-title>-Secretase Modulator (GSM) Photoaffinity Probes Reveal Distinct Allosteric Binding Sites on Presenilin</article-title>. <source>J. Biol. Chem</source>. <volume>288</volume>, <fpage>9710</fpage>–<lpage>9720</lpage> (<year>2013</year>). <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1074/jbc.M112.398602" xlink:type="simple">10.1074/jbc.M112.398602</ext-link></comment> <object-id pub-id-type="pmid">23396974</object-id></mixed-citation></ref>
<ref id="pcbi.1006228.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Feng</surname> <given-names>Z.</given-names></name>, <name name-style="western"><surname>Hu</surname> <given-names>G.</given-names></name>, <name name-style="western"><surname>Ma</surname> <given-names>S.</given-names></name> &amp; <name name-style="western"><surname>Xie</surname> <given-names>X.-Q.</given-names></name> <article-title>Computational Advances for the Development of Allosteric Modulators and Bitopic Ligands in G Protein-Coupled Receptors</article-title>. <source>AAPS J</source>. <volume>17</volume>, <fpage>1080</fpage>–<lpage>1095</lpage> (<year>2015</year>). <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1208/s12248-015-9776-y" xlink:type="simple">10.1208/s12248-015-9776-y</ext-link></comment> <object-id pub-id-type="pmid">25940084</object-id></mixed-citation></ref>
<ref id="pcbi.1006228.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Teşileanu</surname> <given-names>T.</given-names></name>, <name name-style="western"><surname>Colwell</surname> <given-names>L. J.</given-names></name> &amp; <name name-style="western"><surname>Leibler</surname> <given-names>S.</given-names></name> <article-title>Protein sectors: statistical coupling analysis versus conservation</article-title>. <source>PLoS Comput. Biol</source>. <volume>11</volume>, <fpage>e1004091</fpage> (<year>2015</year>). <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pcbi.1004091" xlink:type="simple">10.1371/journal.pcbi.1004091</ext-link></comment> <object-id pub-id-type="pmid">25723535</object-id></mixed-citation></ref>
<ref id="pcbi.1006228.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jardetzky</surname> <given-names>O.</given-names></name> <article-title>Protein dynamics and conformational transitions in allosteric proteins</article-title>. <source>Prog. Biophys. Mol. Biol</source>. <volume>65</volume>, <fpage>171</fpage>–<lpage>219</lpage> (<year>1996</year>). <object-id pub-id-type="pmid">9062432</object-id></mixed-citation></ref>
<ref id="pcbi.1006228.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Huang</surname> <given-names>W.</given-names></name> <etal>et al</etal>. <article-title>Allosite: a method for predicting allosteric sites</article-title>. <source>Bioinformatics</source> <volume>29</volume>, <fpage>2357</fpage>–<lpage>2359</lpage> (<year>2013</year>). <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/bioinformatics/btt399" xlink:type="simple">10.1093/bioinformatics/btt399</ext-link></comment> <object-id pub-id-type="pmid">23842804</object-id></mixed-citation></ref>
<ref id="pcbi.1006228.ref031"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Guarnera</surname> <given-names>E.</given-names></name> &amp; <name name-style="western"><surname>Berezovsky</surname> <given-names>I. N.</given-names></name> <article-title>Structure-Based Statistical Mechanical Model Accounts for the Causality and Energetics of Allosteric Communication</article-title>. <source>PLoS Comput. Biol</source>. <volume>12</volume>, <fpage>e1004678</fpage> (<year>2016</year>). <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pcbi.1004678" xlink:type="simple">10.1371/journal.pcbi.1004678</ext-link></comment> <object-id pub-id-type="pmid">26939022</object-id></mixed-citation></ref>
<ref id="pcbi.1006228.ref032"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mitternacht</surname> <given-names>S.</given-names></name> &amp; <name name-style="western"><surname>Berezovsky</surname> <given-names>I. N.</given-names></name> <article-title>Binding leverage as a molecular basis for allosteric regulation</article-title>. <source>PLoS Comput. Biol</source>. <volume>7</volume>, <fpage>e1002148</fpage> (<year>2011</year>). <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pcbi.1002148" xlink:type="simple">10.1371/journal.pcbi.1002148</ext-link></comment> <object-id pub-id-type="pmid">21935347</object-id></mixed-citation></ref>
<ref id="pcbi.1006228.ref033"><label>33</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mitternacht</surname> <given-names>S.</given-names></name> &amp; <name name-style="western"><surname>Berezovsky</surname> <given-names>I. N.</given-names></name> <article-title>Coherent conformational degrees of freedom as a structural basis for allosteric communication</article-title>. <source>PLoS Comput. Biol</source>. <volume>7</volume>, <fpage>e1002301</fpage> (<year>2011</year>). <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pcbi.1002301" xlink:type="simple">10.1371/journal.pcbi.1002301</ext-link></comment> <object-id pub-id-type="pmid">22174669</object-id></mixed-citation></ref>
<ref id="pcbi.1006228.ref034"><label>34</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Huang</surname> <given-names>W.</given-names></name> <etal>et al</etal>. <article-title>ASBench: benchmarking sets for allosteric discovery: Fig 1</article-title>. <source>Bioinformatics</source> <volume>31</volume>, <fpage>2598</fpage>–<lpage>2600</lpage> (<year>2015</year>). <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/bioinformatics/btv169" xlink:type="simple">10.1093/bioinformatics/btv169</ext-link></comment> <object-id pub-id-type="pmid">25810427</object-id></mixed-citation></ref>
<ref id="pcbi.1006228.ref035"><label>35</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Berezovsky</surname> <given-names>I. N.</given-names></name>, <name name-style="western"><surname>Guarnera</surname> <given-names>E.</given-names></name>, <name name-style="western"><surname>Zheng</surname> <given-names>Z.</given-names></name>, <name name-style="western"><surname>Eisenhaber</surname> <given-names>B.</given-names></name> &amp; <name name-style="western"><surname>Eisenhaber</surname> <given-names>F.</given-names></name> <article-title>Protein function machinery: from basic structural units to modulation of activity</article-title>. <source>Curr. Opin. Struct. Biol</source>. <volume>42</volume>, <fpage>67</fpage>–<lpage>74</lpage> (<year>2017</year>). <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.sbi.2016.10.021" xlink:type="simple">10.1016/j.sbi.2016.10.021</ext-link></comment> <object-id pub-id-type="pmid">27865209</object-id></mixed-citation></ref>
<ref id="pcbi.1006228.ref036"><label>36</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Popovych</surname> <given-names>N.</given-names></name>, <name name-style="western"><surname>Tzeng</surname> <given-names>S.-R.</given-names></name>, <name name-style="western"><surname>Tonelli</surname> <given-names>M.</given-names></name>, <name name-style="western"><surname>Ebright</surname> <given-names>R. H.</given-names></name> &amp; <name name-style="western"><surname>Kalodimos</surname> <given-names>C. G.</given-names></name> <article-title>Structural basis for cAMP-mediated allosteric control of the catabolite activator protein</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A</source>. <volume>106</volume>, <fpage>6927</fpage>–<lpage>6932</lpage> (<year>2009</year>). <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.0900595106" xlink:type="simple">10.1073/pnas.0900595106</ext-link></comment> <object-id pub-id-type="pmid">19359484</object-id></mixed-citation></ref>
<ref id="pcbi.1006228.ref037"><label>37</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Townsend</surname> <given-names>P. D.</given-names></name> <etal>et al</etal>. <article-title>The role of protein-ligand contacts in allosteric regulation of the Escherichia coli catabolite activator protein</article-title>. <source>J. Biol. Chem</source>. <volume>290</volume>, <fpage>22225</fpage>–<lpage>22235</lpage> (<year>2015</year>). <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1074/jbc.M115.669267" xlink:type="simple">10.1074/jbc.M115.669267</ext-link></comment> <object-id pub-id-type="pmid">26187469</object-id></mixed-citation></ref>
<ref id="pcbi.1006228.ref038"><label>38</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wu</surname> <given-names>X.</given-names></name> <etal>et al</etal>. <article-title>Structural basis for a reciprocating mechanism of negative cooperativity in dimeric phosphagen kinase activity</article-title>. <source>FASEB J</source>. <volume>24</volume>, <fpage>242</fpage>–<lpage>252</lpage> (<year>2010</year>). <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1096/fj.09-140194" xlink:type="simple">10.1096/fj.09-140194</ext-link></comment> <object-id pub-id-type="pmid">19783784</object-id></mixed-citation></ref>
<ref id="pcbi.1006228.ref039"><label>39</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Smith</surname> <given-names>T. J.</given-names></name> &amp; <name name-style="western"><surname>Stanley</surname> <given-names>C. A.</given-names></name> <article-title>Untangling the glutamate dehydrogenase allosteric nightmare</article-title>. <source>Trends Biochem. Sci</source>. <volume>33</volume>, <fpage>557</fpage>–<lpage>564</lpage> (<year>2008</year>). <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.tibs.2008.07.007" xlink:type="simple">10.1016/j.tibs.2008.07.007</ext-link></comment> <object-id pub-id-type="pmid">18819805</object-id></mixed-citation></ref>
<ref id="pcbi.1006228.ref040"><label>40</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Li</surname> <given-names>M.</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>C.</given-names></name>, <name name-style="western"><surname>Allen</surname> <given-names>A.</given-names></name>, <name name-style="western"><surname>Stanley</surname> <given-names>C. A.</given-names></name> &amp; <name name-style="western"><surname>Smith</surname> <given-names>T. J.</given-names></name> <article-title>The structure and allosteric regulation of mammalian glutamate dehydrogenase</article-title>. <source>Arch. Biochem. Biophys</source>. <volume>519</volume>, <fpage>69</fpage>–<lpage>80</lpage> (<year>2012</year>). <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.abb.2011.10.015" xlink:type="simple">10.1016/j.abb.2011.10.015</ext-link></comment> <object-id pub-id-type="pmid">22079166</object-id></mixed-citation></ref>
<ref id="pcbi.1006228.ref041"><label>41</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Horjales</surname> <given-names>E.</given-names></name>, <name name-style="western"><surname>Altamirano</surname> <given-names>M. M.</given-names></name>, <name name-style="western"><surname>Calcagno</surname> <given-names>M. L.</given-names></name>, <name name-style="western"><surname>Garratt</surname> <given-names>R. C.</given-names></name> &amp; <name name-style="western"><surname>Oliva</surname> <given-names>G.</given-names></name> <article-title>The allosteric transition of glucosamine-6-phosphate deaminase: the structure of the T state at 2.3 Å resolution</article-title>. <source>Structure</source> <volume>7</volume>, <fpage>527</fpage>–<lpage>537</lpage> (<year>1999</year>). <object-id pub-id-type="pmid">10378272</object-id></mixed-citation></ref>
<ref id="pcbi.1006228.ref042"><label>42</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bustos-Jaimes</surname> <given-names>I.</given-names></name>, <name name-style="western"><surname>Ramírez-Costa</surname> <given-names>M.</given-names></name>, <name name-style="western"><surname>De Anda-Aguilar</surname> <given-names>L.</given-names></name>, <name name-style="western"><surname>Hinojosa-Ocaña</surname> <given-names>P.</given-names></name> &amp; <name name-style="western"><surname>Calcagno</surname> <given-names>M. L.</given-names></name> <article-title>Evidence for two different mechanisms triggering the change in quaternary structure of the allosteric enzyme, glucosamine-6-phosphate deaminase</article-title>. <source>Biochemistry</source> <volume>44</volume>, <fpage>1127</fpage>–<lpage>1135</lpage> (<year>2005</year>). <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1021/bi048514o" xlink:type="simple">10.1021/bi048514o</ext-link></comment> <object-id pub-id-type="pmid">15667206</object-id></mixed-citation></ref>
<ref id="pcbi.1006228.ref043"><label>43</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Monod</surname> <given-names>J.</given-names></name>, <name name-style="western"><surname>Changeux</surname> <given-names>J.-P.</given-names></name> &amp; <name name-style="western"><surname>Jacob</surname> <given-names>F.</given-names></name> <article-title>Allosteric proteins and cellular control systems</article-title>. <source>J. Mol. Biol</source>. <volume>6</volume>, <fpage>306</fpage>–<lpage>329</lpage> (<year>1963</year>). <object-id pub-id-type="pmid">13936070</object-id></mixed-citation></ref>
<ref id="pcbi.1006228.ref044"><label>44</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Benkovic</surname> <given-names>S. J.</given-names></name> &amp; <name name-style="western"><surname>deMaine</surname> <given-names>M. M.</given-names></name> <article-title>Mechanism of Action of Fructose 1,6-Bisphosphatase</article-title>. in Advances in <source>Enzymology - and Related Areas of Molecular Biology</source> <fpage>45</fpage>–<lpage>82</lpage> (<year>2006</year>).</mixed-citation></ref>
<ref id="pcbi.1006228.ref045"><label>45</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hines</surname> <given-names>J. K.</given-names></name>, <name name-style="western"><surname>Kruesel</surname> <given-names>C. E.</given-names></name>, <name name-style="western"><surname>Fromm</surname> <given-names>H. J.</given-names></name> &amp; <name name-style="western"><surname>Honzatko</surname> <given-names>R. B.</given-names></name> <article-title>Structure of inhibited fructose-1,6-bisphosphatase from Escherichia coli: distinct allosteric inhibition sites for AMP and glucose 6-phosphate and the characterization of a gluconeogenic switch</article-title>. <source>J. Biol. Chem</source>. <volume>282</volume>, <fpage>24697</fpage>–<lpage>24706</lpage> (<year>2007</year>). <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1074/jbc.M703580200" xlink:type="simple">10.1074/jbc.M703580200</ext-link></comment> <object-id pub-id-type="pmid">17567577</object-id></mixed-citation></ref>
<ref id="pcbi.1006228.ref046"><label>46</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wright</surname> <given-names>S. W.</given-names></name> <etal>et al</etal>. <article-title>Anilinoquinazoline Inhibitors of Fructose 1,6-Bisphosphatase Bind at a Novel Allosteric Site: Synthesis, In Vitro Characterization, and X-ray Crystallography</article-title>. <source>J. Med. Chem</source>. <volume>45</volume>, <fpage>3865</fpage>–<lpage>3877</lpage> (<year>2002</year>). <object-id pub-id-type="pmid">12190310</object-id></mixed-citation></ref>
<ref id="pcbi.1006228.ref047"><label>47</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hsu</surname> <given-names>W.-C.</given-names></name>, <name name-style="western"><surname>Hung</surname> <given-names>H.-C.</given-names></name>, <name name-style="western"><surname>Tong</surname> <given-names>L.</given-names></name> &amp; <name name-style="western"><surname>Chang</surname> <given-names>G.-G.</given-names></name> <article-title>Dual functional roles of ATP in the human mitochondrial malic enzyme</article-title>. <source>Biochemistry</source> <volume>43</volume>, <fpage>7382</fpage>–<lpage>7390</lpage> (<year>2004</year>). <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1021/bi049600r" xlink:type="simple">10.1021/bi049600r</ext-link></comment> <object-id pub-id-type="pmid">15182181</object-id></mixed-citation></ref>
<ref id="pcbi.1006228.ref048"><label>48</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tang</surname> <given-names>Q.</given-names></name>, <name name-style="western"><surname>Alontage</surname> <given-names>A. Y.</given-names></name>, <name name-style="western"><surname>Holyoak</surname> <given-names>T.</given-names></name> &amp; <name name-style="western"><surname>Fenton</surname> <given-names>A. W.</given-names></name> <article-title>Exploring the limits of the usefulness of mutagenesis in studies of allosteric mechanisms</article-title>. <source>Hum. Mutat</source>. <volume>38</volume>, <fpage>1144</fpage>–<lpage>1154</lpage> (<year>2017</year>). <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/humu.23239" xlink:type="simple">10.1002/humu.23239</ext-link></comment> <object-id pub-id-type="pmid">28459139</object-id></mixed-citation></ref>
<ref id="pcbi.1006228.ref049"><label>49</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chandramohan</surname> <given-names>A.</given-names></name> <etal>et al</etal>. <article-title>Predicting allosteric effects from orthosteric binding in Hsp90-ligand interactions: Implications for fragment-based drug design</article-title>. <source>PLoS Comput. Biol</source>. <volume>12</volume>, <fpage>e1004840</fpage> (<year>2016</year>). <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pcbi.1004840" xlink:type="simple">10.1371/journal.pcbi.1004840</ext-link></comment> <object-id pub-id-type="pmid">27253209</object-id></mixed-citation></ref>
<ref id="pcbi.1006228.ref050"><label>50</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gehrig</surname> <given-names>S.</given-names></name> <etal>et al</etal>. <article-title>An engineered photoswitchable mammalian pyruvate kinase</article-title>. <source>FEBS J</source>. <volume>284</volume>, <fpage>2955</fpage>–<lpage>2980</lpage> (<year>2017</year>). <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/febs.14175" xlink:type="simple">10.1111/febs.14175</ext-link></comment> <object-id pub-id-type="pmid">28715126</object-id></mixed-citation></ref>
<ref id="pcbi.1006228.ref051"><label>51</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Berman</surname> <given-names>H. M.</given-names></name> <etal>et al</etal>. <article-title>The Protein Data Bank</article-title>. <source>Acta Crystallogr. D Biol</source>. <source>Crystallogr</source>. <volume>58</volume>, <fpage>899</fpage>–<lpage>907</lpage> (<year>2002</year>).</mixed-citation></ref>
<ref id="pcbi.1006228.ref052"><label>52</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Krissinel</surname> <given-names>E.</given-names></name> &amp; <name name-style="western"><surname>Henrick</surname> <given-names>K.</given-names></name> <article-title>Inference of macromolecular assemblies from crystalline state</article-title>. <source>J. Mol. Biol</source>. <volume>372</volume>, <fpage>774</fpage>–<lpage>797</lpage> (<year>2007</year>). <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jmb.2007.05.022" xlink:type="simple">10.1016/j.jmb.2007.05.022</ext-link></comment> <object-id pub-id-type="pmid">17681537</object-id></mixed-citation></ref>
<ref id="pcbi.1006228.ref053"><label>53</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hinsen</surname> <given-names>K.</given-names></name>, <name name-style="western"><surname>Petrescu</surname> <given-names>A.-J.</given-names></name>, <name name-style="western"><surname>Dellerue</surname> <given-names>S.</given-names></name>, <name name-style="western"><surname>Bellissent-Funel</surname> <given-names>M.-C.</given-names></name> &amp; <name name-style="western"><surname>Kneller</surname> <given-names>G. R.</given-names></name> <article-title>Harmonicity in slow protein dynamics</article-title>. <source>Chem. Phys</source>. <volume>261</volume>, <fpage>25</fpage>–<lpage>37</lpage> (<year>2000</year>).</mixed-citation></ref>
<ref id="pcbi.1006228.ref054"><label>54</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hinsen</surname> <given-names>K.</given-names></name> <article-title>The molecular modeling toolkit: A new approach to molecular simulations</article-title>. <source>J. Comput. Chem</source>. <volume>21</volume>, <fpage>79</fpage>–<lpage>85</lpage> (<year>2000</year>).</mixed-citation></ref>
<ref id="pcbi.1006228.ref055"><label>55</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hinsen</surname> <given-names>K.</given-names></name> <article-title>Analysis of domain motions by approximate normal mode calculations</article-title>. <source>Proteins</source> <volume>33</volume>, <fpage>417</fpage>–<lpage>429</lpage> (<year>1998</year>). <object-id pub-id-type="pmid">9829700</object-id></mixed-citation></ref>
<ref id="pcbi.1006228.ref056"><label>56</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pettersen</surname> <given-names>E. F.</given-names></name> <etal>et al</etal>. <article-title>UCSF Chimera—a visualization system for exploratory research and analysis</article-title>. <source>J. Comput. Chem</source>. <volume>25</volume>, <fpage>1605</fpage>–<lpage>1612</lpage> (<year>2004</year>). <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/jcc.20084" xlink:type="simple">10.1002/jcc.20084</ext-link></comment> <object-id pub-id-type="pmid">15264254</object-id></mixed-citation></ref>
</ref-list>
</back>
</article>